Wharton

MBA Program in Health Care Management

2018 RESUME BOOK Contents Program Description ...... 4 Curriculum ...... 5 Graduates ...... 6-30 Internship Sponsors...... 31 Health Care Program Mentors ...... 32-36 Administration ...... 37 Faculty ...... 38-39

Thank you for your interest in the Wharton MBA Program in Health Care Management. For further information, resumes, and appointments, contact:

June Kinney, Associate Director, MBA Program in Health Care Management The Wharton School University of Pennsylvania 3641 Locust Walk Philadelphia, PA 19104-6218

215.898.6861 | Fax 215.573.2157 email: [email protected]

For information on the Wharton Health Care Management Alumni Association, visit www.whartonhealthcare.org

For detailed information on the Health Care Management Department educational programs, visit http://mba.wharton.upenn.edu/healthcare/ 2018 Health Care Management

M.B.A. Graduates The University of Pennsylvania was founded by Benjamin Franklin in 1740. Although the University carries the name of the Commonwealth, it is not a state university but an independent, private, nonsectarian institution. As one of the country’s earliest educational institutions, it has consistently initiated advances in teaching and research and has steadily generated specialized fields of higher education. Penn, as the University is commonly known, was the first American university to form departments of botany, hygiene and public health, surgical research, and research medicine. The University School of Medicine, formed in 1765, was the first in North America, as was the teaching hospital founded in 1874. The world’s first psychological clinic was opened at Penn in 1896.

The Wharton School, in the same spirit of innovation and excellence, was the world’s first collegiate school of business and management. Founded in 1881 with a gift from Joseph Wharton, the Philadelphia industrialist and philanthropist, the Wharton School undertook the pioneer steps in elevating training for business significantly above its previous level as noncollegiate commercial education. In 1921, the formation of the Graduate Program signaled the advancement of business administration at Wharton to the highest levels of professional education.

Today, the Wharton School has more than 270 faculty members teaching in both the graduate and undergraduate divisions and conducting a continually expanding volume of research. The 1,700 students in the master’s degree program may choose from among more than 200 courses and over 18 majors and concentrations, a variety reflecting the fact that the Wharton education complements the career goals of the individual.

This brochure is provided to introduce you to the 2018 Wharton Health Care Management Program graduates.

We encourage you to consider these individuals for employment.

3 Program Description

The Graduate Program in Health Care Management The Leonard Davis Institute of Health Economics is a full-time two-year MBA curriculum offered (LDI) is an interdisciplinary center for research by the Health Care Management Department of and education in the organization, financing, the Wharton School. The program, the principal and delivery of health care. Through LDI, University educational effort at the Leonard Davis Institute of Pennsylvania faculty and staff work together of Health Economics, is designed to provide on issues concerning health policy, health managerial and technical expertise to students insurance, managed care, hospitals, corporations, interested in the health care management field. pharmaceutical companies, and other health- By combining the skills of the Wharton disciplines related organizations. Established in 1967, the with sensitivity to the needs of health care providers Institute appropriately bears the name of the late and recipients, the Wharton MBA health care Leonard Davis, one of the foremost innovators in graduate can effectively manage the delivery private health insurance in the United States. He of health services and products at all levels. was the founder of Colonial Penn Group, Inc., a company that has pioneered in insurance for older The Program has produced graduates who have Americans. Both Mr. Davis and Mrs. Sophie Davis chosen careers in hospitals and other medical were generous benefactors to the University of institutions, pharmaceutical, biotechnology and Pennsylvania, contributing basic support for the medical device companies, financial services, activities of the Leonard Davis Institute. entrepreneurial ventures, consulting firms, insurance firms, private health industry, and federal, state, and local government. Many of these MBA graduates now hold positions as chief executive officers, directors, and other key decision makers in health care organizations.

4 Curriculum The Wharton Management Core

All students are required to complete the Wharton Management International Programs: Core. The Wharton School’s core curriculum is designed to Global Modular Courses: Short full-credit courses in an increase crossfunctional integration, extend global experience, intensive workshop format in a country relevant to the topic. strengthen leadership training, and introduce new courses on key management issues. The core curriculum provides Global Immersion Program (GIP): groundwork in basic management disciplines: economics, A high-level survey of the economic, cultural, and geo- finance, financial and cost accounting, management science, political drivers behind regions integral to the global managing people and organizational design, marketing, economy. Students then experience it in-country. operations management, the governmental and legal environment of business, statistics, and strategy. The Health Care Major Courses and Electives: These courses promote an understanding of concepts, Fixed Core: institutions, and issues involved in the organization, • Leadership: Foundations of Teamwork and Leadership financing, and delivery of health services and products • Marketing: Marketing Management in the United States. Health care electives are selected • Microeconomics: Microeconomic Foundation consistent with individual career objectives and interests. • Economics: Advanced Topics in Managerial Economics • Statistics: Regression Analysis for Managers Required • Management Communication: Speaking and Writing • Health Services System • Health Care Field Application Project Flexible Core: Operations, Information, and Decisions Electives • Quality and Productivity • Comparative Health Care Systems • Business Analytics • Financial Management of Health Care Organizations • Information Technology and Business Transformation • Managed Care, Market Structure, and • Innovation Health Care Delivery • Operations Strategy • Health Care Reform • Management and Economics of Marketing Pharmaceutical and Biotechnology Industry • Dynamic Marketing Strategy • Medical Devices • Strategic Marketing Simulations • Management of Health Care for the Elderly • E-Health: Business Models and Impact Communications • Management of Health Care Services Businesses • Advanced Persuasive Speaking • Health Care Entrepreneurship • Communications Challenges for Entrepreneurs • Private Sector Role in Global Health • Health Care Services Delivery: Accounting A Managerial Economic Approach • Financial Accounting • Advanced Study Project • Accelerated Financial Accounting • Financial and Managerial Accounting The Health Care Summer Internship The internship is a three-month management experience Corporate Finance that provides the health care major an opportunity • Corporate Finance to work with a senior executive in an organization of • Accelerated Corporate Finance particular interest to the student. • Introduction to Corporate Finance MBA Electives Macroeconomics Opportunities are available for the health care major • Macroeconomics to pursue a second concentration in fields such as entre- • Introduction to Macroeconomics preneurship, marketing, finance, or operations, or to pursue specialized knowledge in areas such as health care Management financing or within specialized segments of the health care • Managing the Established Enterprise industry including managed care organizations, hospitals, • Managing the Emerging Enterprise pharmaceutical and biotechnology companies, medical device companies, specialty services organizations, and Legal Studies & Business Ethics long term care organizations. Graduate courses are • Responsibility in Global Management available throughout the University. • Responsibility in Business

5 Susan M. Adler Joseph Earl Alex Aptekman [email protected] [email protected] University of Rochester, Rochester, NY Anderson York University, Schulich School of Business, B.A., Cum Laude, Economics, Philosophy, 2011 [email protected] Toronto, Canada Vanderbilt University, Nashville, TN B.B.A., Highest Honors, Finance, 2009 B.A., Mathematics, Economics, 2011

An opportunity to make a meaningful An opportunity to identify, build, An opportunity to bring transformative impact on the commercialization of and direct market-leading healthcare change to the behavioral health space innovative products for a biopharma- companies through a private equity by helping to build outcomes-focused ceutical company. investment role. businesses.

Sanofi Genzyme, Cambridge, MA MBF Healthcare Partners, Miami, FL DW Healthcare Partners, U.S. Marketing Associate, Summer 2017 Summer Vice President, Summer 2017 Toronto, Canada Prepared for pediatric launch of a first Assessed investment opportunities, Vice President, 2016 in class biologic to treat dermatologi- performed financial and business Senior Associate, 2015 cal disease. Conducted expert inter- due diligence, and assisted portfolio Associate, 2013-2014 views with HCPs, designed and company managers for $350M middle- Executed three platform acquisitions, implemented Pediatrician survey. market healthcare focused private focusing on financial modeling, Developed recommendations for equity fund. Identified and evaluated diligence, and lender negotiations for HCP target segments and Pediatrician subsectors within healthcare services a healthcare private equity fund with engagement and presented to senior and led fund-wide strategy refresh. $900M AUM. Appointed to senior management. Findings and recom- Monitored portfolio company perfor- management positions (interim CEO; mendations adopted into brand plan. mance and served as summer board CFO) at the largest provider of addic- observer for Palm Medical Centers tion treatment services in Canada, The Boston Consulting Group, (risk-bearing provider) and Concordia Canadian Addiction Treatment Centres Boston, MA Care (complex care management). (portfolio company with 75 clinics), Senior Knowledge Analyst, 2015-2016 managing a major change in reim- Knowledge Analyst, 2013-2015 Evolent Health, Arlington, VA bursement. Developed a business case Served as U.S. biopharma commercial Associate, Corporate Development, that resulted in a transformative JV expert, providing original analysis and 2015-2016 between the portfolio company and support for over 40 client engage- Senior Analyst, Corporate Development, Gilead to administer a Hepatitis C ments. Developed U.S. drug pricing 2014-2015 treatment to patients. compendium for global pharmaceuti- Sourced, evaluated, and executed cal company, devised tailored M&A transactions as lead M&A Union Square Advisors, San Francisco, CA company positioning statements. associate on Corporate Development Senior Analyst, Technology Investment Conducted market access benchmark- team. Directed due diligence efforts, Banking, 2011-2012 ing effort of 13 global pharmaceutical conducted detailed financial modeling Advised on M&A transactions companies. Interviewed market access, and analysis, managed third-party for strategic and financial clients. policy, and real-world data senior advisors, structured purchase agree- Managed the big data initiative, leadership and created customized ments, and developed 100-day working on all firm deals in this benchmark analyses. go-to-market strategies for 2 space, including the $500M sale of completed transactions: $220M acqui- DemandTec, a cloud-based analytics Public Consulting Group, Boston, MA sition of Valence Health (managed software provider, to IBM. Promoted Business Analyst, 2011-2013 and value based care technology to Third Year Analyst; top-tier ranking Conducted planning and design and services), $15M carve-out and in every review. of multiple ACA-compliant health acquisition of Passport Health Plan’s insurance exchanges. Assisted in the operating assets. Bank of America Merrill Lynch, development of Delaware exchange Toronto, Canada consumer assistance and plan manage- Deloitte Consulting, Atlanta, GA Analyst, Global Investment Banking, ment functions. Created report on Consultant, 2013-2014 2009-2010 Texas’ behavioral health delivery Business Analyst, 2011-2013 Advised on cross-border M&A and system, providing recommendations Advised healthcare and financial financing transactions for clients for reform to the Texas Legislature. services clients as part of Strategy across numerous industries. Ranked and Operations practice. in the top five percent of an incoming class of 350 analysts in the 2009 Global Training Program.

6 Priyadarshini Charnice A. Barbour Aya BenDavid [email protected] [email protected] Banerjee Dartmouth College, Hanover, NH The Interdisciplinary Center (IDC), priyadarshini.banerjee.wg18@ A.B., Engineering Sciences, 2010 Herzliya, Israel wharton.upenn.edu M.E.M., Engineering Management, 2012 LL.B., Law, B.A., Business Administration, 2011 National University of Singapore, Singapore Bachelor of Engineering (B.Eng.), Computer Engineering, 2012

An opportunity to identify, invest in, An opportunity to work on effective An opportunity to improve patients’ and transform innovative healthcare teams within health care to improve access to care through developing and services and technology companies. operational and strategic initiatives. executing strategies for pharmaceutical companies. ROCA Partners, Los Angeles, CA Barclays Investment Bank, New York, NY Investment Team, Summer 2017 Healthcare Investment Banking Associate, Novartis AG, East Hanover, NJ Led business and financial diligence Summer 2017 Strategy Associate, Summer 2017 for a $50M investment in a women’s Advised on over 10 transactions, Identified, planned, and executed health and cancer diagnostics com- including buy-side M&A and dual-track large-scale strategy project impacting pany at this new private equity fund, IPO/M&A for top pharmaceutical, growth plans for a third of the founded by former executives at Ares medical device, and healthcare service Melanoma Brand within the Oncology Management. companies. Business Unit. Analyzed research and partnered with vendors to recommend Venrock, New York, NY Trinity Partners, Waltham, MA data-driven solutions for new patient Investment Associate, Summer 2017 Consultant, 2014-2016 segment. Received acknowledgement Created investment theses in robotics Senior Associate Consultant, 2014-2014 from senior leadership who chose to and computer vision. Co-led business Associate Consultant, 2012-2013 integrate findings in upcoming launch and financial diligence of $5M series A Conducted market research, data plans. investment in an insurance technology analyses, and due diligence for 45+ startup. projects, serving over 20 leading and Pentax Medical, Hamburg, Germany emerging pharmaceutical, medical Director of Global Product Management, Sequoia Capital, Mumbai, India device, and biotech companies in key 2014-2016 Investment Analyst, Venture Capital therapeutic areas such as oncology Led product development process and and Growth Equity, 2014-2016 and diabetes. Project highlights: launch of 4 products in the German Led financial and business due (1) examined yearly results from an R&D center, employing 40 engineers; diligence for investments in healthcare Awareness, Trial, and Usage quantita- strategized, planned, and executed and consumer sectors. Initiated and tive survey to assess and ameliorate the global product roadmap and led knowledge building and invest- access issues for a $94B pharmaceutical go-to-market with regional teams. ment sourcing in emerging categories company’s four oncology agents, Led multi-national team of over 100 of healthcare technology; sourced (2) managed a $350K project and members in design and development Sequoia India’s first investment day-to-day activities of a team of of new large-scale technology plat- ($10M series A) focused on precision two identifying levers in the oncology form for gastroenterology, targeting medicine. treatment paradigm prior to product emerging markets; managed project launch to help with regulatory submis- budget of $15M with expected sales McKinsey & Company, Mumbai, India sion for a $2.6B pharmaceutical com- of $330M in first five years. Business Analyst, 2012-2014 pany, (3) determined potential market Created implementation strategy share, target consumers, and market- EarlySense, Tel Aviv, Israel for India’s largest engineering and ing materials of an anti-infective drug Marketing and Product Manager, construction company to scale up for a $7B company by interviewing key 2012-2014 presence from a team of 20 to 200 consumers and analyzing data from Associate Marketing Manager/Site Manager in the Middle East; recommended or- a large international survey. (Los Angeles)/Applications Specialist, ganizational process changes leading 2008-2011 to margin improvements of ~12-15%. Promoted 5 times as the organization Built the strategy and execution expanded from 20 to over 100 employ- blueprint for a global non-profit ees, having demonstrated managerial foundation to electrify 1,000 Indian skills. Initiated new product develop- villages over 5 years. Created 5-year ment, resulting in: 60% reduction in growth strategy for “Top 3” Indian unit price, greater affordability for pharmaceuticals company to achieve hospitals, and 300% increase in sales market leadership. per average deal.

7 Gregory E. Berger Luke A. Betterman Alastair M. [email protected] [email protected] Blake, M.D. Dartmouth College, Hanover, NH University of Notre Dame, South Bend, IN B.A., Magna Cum Laude, English B.A., Magna Cum Laude, History, 2011 [email protected] and Psychology, 2012 University of Cambridge, UK B.A, Physiology & Neurosciences, 2009 University of Cambridge, UK MB/BChir (M.D.), 2012

An opportunity to work in a strategic An opportunity to operate and invest An opportunity to improve healthcare role that drives healthcare transforma- in innovative healthcare technology access and delivery through innovative tion from a volume-based world to and services companies. care models and technology. value-based models. Medtronic, Boulder, CO McKinsey & Company, Boston, MA DaVita Healthcare Partners, Denver, CO Business Development Associate, Summer Associate, Summer 2017 Redwoods Summer Associate, Summer 2017 Summer 2017 Advised large hospital system on As part of the corporate strategy Developed investment roadmap for cost saving strategy, including clinical team, analyzed the performance of Surgical Innovations business, utilizing service redesign. Worked with client DaVita’s primary care business in two a detailed investment thesis frame- leadership to identify savings opportu- markets, and initially focused on new work to evaluate acquisition opportu- nities and develop rigorous monthly marketing strategies to attract more nities totaling $750M (5 year revenue). implementation and reporting Medicare Advantage patients. Halfway Coordinated due diligence process for practices. through the summer, shifted focus to potential $150M acquisition, liaising analyzing possible patient attrition with external partners and 100+ inter- Barts Health NHS Trust and NW London causes, and developing strategies nal team members across commercial, Hospitals NHS Trust, London, UK to combat those hypotheses. R&D and operations functions. Resident Physician, Internal Medicine, 2015-2016 and 2012-2014 Oliver Wyman, New York, NY Springhill Consulting Group, Chicago, IL Led ward rounds and successfully Engagement Manager, 2016 Director, 2014-2016 treated over 1,500 patients per year Associate, 2015 Manager, 2013-2014 in emergency and outpatient settings. Senior Consultant, 2014 Analyst, Senior Analyst, 2011-2013 Led a three-person team on project Consultant, 2012-2013 Managed up to 4 project teams that reduced waiting times by 45% Strategy consultant in the Health & simultaneously in executing strategic for patients with Achilles tendon Life Sciences practice, with a focus engagements, including: M&A due rupture. Won “Excellence in on payer and provider clients. Project diligence support, market opportunity Leadership Award” for contribution work primarily related to developing analysis, competitive landscape assess- to local quality improvement work. winning strategies in the ever-chang- ment, and performance benchmark- ing healthcare environment for the ing. Project highlights: (1) Identified Care Quality Commission, London, UK individual ACA and Medicare efficiency opportunities totaling National Medical Director’s Clinical Fellow, Advantage markets, as well as ~$150M for a Fortune 100 distributor 2014-2015 driving the shift to value-based care. with $2B+ operating expense (SG&A); Led six-person team to design and Additional project work included (2) Managed a team of four analysts deliver an innovative best practice developing a first-of-its-kind private in the global strategic assessment of website for primary care providers. exchange for health insurance and a prototype percutaneous surgical Site was used over 10,000 times in the financial products for a national device, recommending $25M+ invest- first 2 weeks and was shortlisted for membership association, and design- ment based on market opportunity Health Service Journal Award. ing a new chronic kidney disease care and strategic fit; (3) Presented seg- Demonstrated thought-leadership by model for an international dialysis mented survey data and insights to publishing 4 peer-reviewed academic provider. Across projects, managed executive leadership of a Fortune papers in high impact journals and a several teams of up to five consultants 500 orthopedics company, directly textbook chapter on regulatory policy. as project manager, served as primary influencing core elements of its 2013 client liaison, and conducted complex strategic plan. claims analyses.

8 James A. Timothy A. Carlon Gregory G. Certo [email protected] [email protected] Calderwood, R.N. Duke University, Durham, NC Dartmouth College, Hanover, NH [email protected] B.S.E., Summa Cum Laude, Biomedical A.B., Chemistry and Religion, 2012 University of Pennsylvania, Philadelphia, PA Engineering, 2013 B.S., Economics, 2012 Perelman School of Medicine at the University B.S., Nursing, 2012 of Pennsylvania, Philadelphia, PA M.D. Candidate, 2018

An opportunity to work in strategy or An opportunity to help health care An opportunity to support the develop- business development focused on the organizations adapt to and succeed ment and commercialization of thera- future of healthcare. in value-based payment models. peutics and healthcare products through investment or business development. Cleveland Clinic, Cleveland, OH Cigna, Philadelphia, PA Strategy Intern, Summer 2017 Value-Based Reimbursement Summer Oberland Capital, New York, NY Worked with executives and clinical Associate, Summer 2017 Summer Associate, Summer 2017 leaders to create a provider staffing Developed a strategy to accelerate the Analyzed investment opportunities report based on predicted changes in growth of episode-based contracts for at firm offering structured financing technology, population health, spe- procedures as part of Cigna’s commit- solutions to the global healthcare cialty care, etc.; conducted analyses on ment to matching the Centers for industry. Worked to provide deal regional expansion; evaluated oppor- Medicare and Medicaid Services goals sourcing, conducted investment tunities for the Clinic’s $8B investment of tying 90% of payments to quality diligence, and assessed potential fund including diligence and financial and delivering 50% of reimbursements deal structures. analysis with the Finance Office. through alternative models. Conducted stakeholder interviews and Locust Walk Partners, Boston, MA Advanced Medical Technology built tools quantifying the value of Analyst, 2014-2016 Association (AdvaMed), Washington, DC concrete practice changes for partner Evaluated and supported buy- and Policy Analyst, 2015-2016 groups. Presented final report and sell-side biopharmaceutical transac- Research Associate, 2012-2015 recommendations to senior leadership tions. Performed due diligence, Utilized R statistical suite to analyze including the CMO and multiple vice authored management presentations, CMS databases and create custom presidents. assessed commercial landscapes and financial/marketing reports, which market opportunities, built financial encouraged creation of a for-profit Computational Breast Imaging Group, models, wrote term sheets, analyzed entity; developed financial impact Philadelphia, PA deal scenarios, conducted screens, and models based on interpretations of Graduate Researcher, 2014 prioritized target opportunities. CMS rules; assisted in managing re- Authored MATLAB code for auto- search budget of $1M+; supported mated analysis of breast MRI images Health Advances, Weston, MA medtech start-ups in navigating FDA, with the goal of quantifying risk of Analyst, 2012-2014 CMS, and private payer spaces. future breast and ovarian cancers in Strategy consultant to the healthcare asymptomatic women with BRCA 1 industry supporting drug, device, U.S. Senate, Washington, DC and BRCA 2 mutations. Improved diagnostics, and investment clients. Health Policy Fellow, 2012 previously developed algorithms by Quantified market opportunities, Worked in Senator’s office under reducing run time by 50%, reducing assessed competitive landscapes, sponsorship from the Kaiser Family failure rate from 25% to <5%, and and performed primary research. Foundation on healthcare policy adding extensive comments and help issues, including healthcare reform, files to >10 programs in preparation CMS, and Native Americans; consulted for analysis of larger, more diverse the Senator on diverse topics, includ- image datasets. Coordinated with ing drinking water, pharmaceuticals post-doctoral researchers by providing and HIV/AIDS; presented the potential clinical context to direct appropriate effects and mitigation of sequestration applications of novel algorithms. on the Indian Health Service. Presented results to the principal investigator, guiding future direction of the project.

9 Elena H. Chit Matthew E. Delaney Lena E. Evans [email protected] [email protected] [email protected] Harvard College, Cambridge, MA Bowdoin College, Brunswick, ME Columbia University, New York, NY A.B., Government, 2012 B.A., Cum Laude, Economics and B.A., English, 2008 History Double Major, 2011

An opportunity to build, launch, and An opportunity to guide products An opportunity to serve health care implement technology-enabled health through the healthcare system to make companies interested in strategic and products, services, and operating mod- sure the right treatment gets to the operational innovation. els, especially to care for underserved right patient. populations. Pfizer, New York, NY Pfizer, New York, NY Marketing MBA Summer Associate, Accolade, Plymouth Meeting, PA Marketing MBA Summer Intern, Summer 2017 Corporate Strategy Intern, Summer 2017 Summer 2017 Led the assessment of the payer access Developed detailed P&L category-level Led U.S. launch team of a rare disease landscape for a newly launched prod- comparisons of key competitor’s head- drug, consisting of over two-dozen uct and identified insights related to count and spend; presented findings employees up to the Director level. patient behavior at certain access lev- to founder, CEO and direct reports; Created the launch project manage- els. Conducted diligence on internal intended to result in modifying 2018 ment process from the ground up, and external tools for access improve- budget spend and compensation ap- including writing a detailed launch ment and presented recommendations proach. Synthesized key competitor’s work plan, organizing and leading to management for incorporation into full current, non-public customer list to team meetings, creating a budget, the brand’s tactical plan. inform product development strategy and tracking progress against ~300 key and customer segmentation, target- activities and milestones. Ultimately, Russo Partners LLC, New York, NY ing, pricing, contracting, and third- wrote and presented a brand operat- Assistant Vice President, 2015-2016 party administrator engagement ing plan laying out the launch strategy Account Supervisor, 2013-2014 strategies. to the Global President of Rare Senior Account Executive, 2012 Diseases. Account Executive, 2011 IBM, New York, NY Assistant Account Executive, 2010 Corporate Strategy Senior Consultant, L.E.K. Consulting, Boston, MA Managed $1.5M in annual revenue 2015-2016 Associate, 2011-2013 for a boutique healthcare PR agency Global Business Services Senior Consultant, Associate Consultant, 2013-2014 serving public and private clients in 2014-2015 Life Sciences Sector Specialist, 2014-2016 the biotech, pharma, and medical Global Business Services Consultant, Managed work streams, conducted device industries. Developed and exe- 2012-2014 research, and developed deliverables cuted successful PR campaigns for 45+ Analyzed historical revenue, cost and in 20+ projects for top companies in clients and oversaw 5 direct reports. growth performance for two business Life Sciences and beyond. Examples units; rationalized portfolio offerings, include a small pharma corporate Consorzio Mario Negri Sud, reduced complexity and reassigned in- strategy, an immunology drug royalty Santa Maria Imbaro, Italy vestment to higher growth products. monetization, and a medtech brand Manuscript Editor, Laboratory of Defined 3-year strategy for new busi- relaunch. As the Sector Specialist, Lipid Metabolism and Cancer, 2009 ness unit’s growth target through drove internal initiatives to support Collaborated with researchers to competitive assessment and client en- the 17 Managing Directors of the U.S. develop and submit manuscripts gagement with 30 developer teams, Life Sciences practice, including a for peer-reviewed publication. system integrators and independent major knowledge capture initiative. software vendors. Managed $400K Salk Institute for Biological Studies, project P&L, strategy and delivery for La Jolla, CA cross-functional 7-person team to con- Lab Assistant, Gene Expression Laboratory, duct clinical, technical, and regulatory 2008 need-gap analysis and develop solu- Coordinated the submission of a tion implementation roadmap for multi-institute grant to the California $1.2B city public health agency. Institute for Regenerative Medicine.

10 Melanie M. Fan Aileen Fernandes Neha A. Gavai [email protected] [email protected] [email protected] Duke University, Durham, NC The Wharton School, University of Cornell University, Ithaca, NY B.S., Cum Laude, Economics and Statistical Pennsylvania, Philadelphia, PA A.B., Cum Laude, Biological Sciences, A.B., Science, 2012 B.Sc., Cum Laude, Economics: Organizational Economics, 2012 Effectiveness Management and Operations & Information Management, 2011

An opportunity to identify and build An opportunity to improve patient care An opportunity to grow early stage market-leading healthcare companies through developing and executing inno- digital health companies that seek through an investment or operational vative strategies in healthcare services. to optimize care delivery and patient role. outcomes. Doximity, San Francisco, CA Doximity, San Francisco, CA Business Development Intern, Summer 2017 Oncora Medical, Philadelphia, PA Business Development Intern, Summer 2017 Worked with founders and executive Business Development Intern, Summer 2017 Worked directly with co-founders and team to evaluate market landscape Led development of customer acquisi- senior management team of digital of hospital product, and recommend tion strategy, investor pitch materials, health startup, building an online net- repositioning and expansion strategy and project management initiatives. work for medical professionals with to increase business from $6M to $10M Spearheaded an analysis that identi- >70% of U.S. physicians on platform. in next six quarters. fied a 17% unplanned hospital admis- Led initiative to analyze demographics sion rate among patients undergoing and engagement for physicians Amino, San Francisco, CA radiation therapy and built a model to targeted by pharmaceutical clients, MBA Intern, Summer 2016 project $7M annual savings in hospital resulting in actionable insights for Directed API business development admissions costs achieved by Oncora’s increasing advertising revenue and strategy; pitched product feature to software product at a single large strategic recruitment of new members. 100+ health organizations, resulting health system. Redefined Oncora’s in 6 signed contracts and an active value proposition and target market Frazier Healthcare Partners, Seattle, WA pipeline of 30+ clients. in preparation for funding pitches. Growth Buyout Associate, 2014-2016 Assessed over 30 potential investment Deloitte Consulting, San Francisco, CA Strategy& (formerly Booz & Company), opportunities and executed leveraged Consultant, 2014-2016 New York, NY buyout transactions for a middle- Business Analyst, 2013-2014 Senior Associate, Life Sciences Strategy, market healthcare services-focused Strategy consultant with focus on 2015-2016 private equity firm with over $2.9B of human capital strategy and operations Associate, PwC Health Industries Advisory, committed capital. Collaborated with for health systems and life science 2012-2014 management teams of 5 portfolio companies. Project work included Advised pharmaceutical and life companies to achieve financial and customer experience strategy, current sciences clients on customer strategies, operational targets, assess strategic state assessments, future state and including patient engagement, digital alternatives and analyze add-on acqui- process design, and operational health, and product life cycle manage- sitions. Successfully closed 4 platform improvement. Project highlights: ment. Project highlights included acquisitions (Golden State Medical (1) development of Deloitte’s Wharton designing an innovative program Supply, Leiter’s Compounding, United Physician Leadership Academy market to address metastatic breast cancer Derm Partners, Center for Orthopedic analysis and curriculum strategy, patient needs, preparing a cost model Research and Excellence) and 1 portfo- (2) human capital technology assess- to evaluate feasibility of potential lio company sale (PCI Pharma Services). ment for pharmaceutical company. patient engagement pilots, and gener- ating a pricing and contracting ap- UBS Investment Bank, New York, NY Morgan Stanley, New York, NY proach to position a flagship drug Global Healthcare Group Analyst, Strategy, Operations, & Technology effectively after patent expiration. 2012-2014 Financial Analyst, 2011-2013 Contributed to a nationally recognized Executed debt, equity, and M&A Executive strategy team reporting PwC Health Research Institute thought transactions for mid- to large-cap to CFO tasked with transforming the leadership report that focuses on the healthcare companies. company’s global workforce footprint evolving landscape of the healthcare by 2016, targeting growth in emerging ecosystem and the expanding role of market assets and $180M in operational healthcare’s new entrants. expenditure savings.

11 Michael L. Gebhardt Geoff M. Gusoff Eason Hahm [email protected] [email protected] [email protected] Northwestern University, Evanston, IL Brown University, Providence, RI Harvard College, Cambridge, MA B.A., Economics, 2011 A.B., Religious Studies and Public Policy, 2007 A.B., Magna Cum Laude with Highest Honors, Boston College, Boston, MA Engineering Sciences, 2012 M.T.S., Social Ethics, 2011 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA M.D. Candidate, 2018

An opportunity to lead and execute An opportunity to improve health and An opportunity to work with biopharma private equity transactions for an its social determinants by providing companies developing transformative established middle-market private primary care and facilitating community medicines through a business equity firm. economic development. development or early-stage venture investing role. Tailwind Capital, New York, NY Esperanza Health Center, MBA Intern, Summer 2017 Philadelphia, PA AbbVie, Inc., North Chicago, IL Evaluated new investment opportuni- Community Health Intern, Summer 2017 AbbVie Ventures Intern, Summer 2017 ties across healthcare, business Developed a business plan and finan- Developed a process to proactively services, and industrial services sectors. cial model for a healthy food café identify early-stage U.S. biotech Oversaw early stages of diligence for to be established in a food desert in companies as potential investment 10+ new deals, including managing North Philadelphia; conducted market opportunities by targeting high-prior- associate resources. Received offer to analysis, internal and external inter- ity accelerators / incubators. Supported return full time as a Vice President. views, and industry research; informed several seed / Series A financed the investment of over $500K of com- portfolio companies and evaluated Riverside Partners, Boston, MA munity health resources. Developed new investment opportunities in Associate, 2014-2016 NPV model for financing options for a oncology, immunology, and neurosci- Evaluated healthcare and technology new clinic site, including New Market ence. Conducted detailed biopharma investment opportunities; supported Tax Credits. Identified best practices corporate venture capital benchmark- investment theses with analysis, man- for emergency room diversion and ing analysis. aged relationships with third-party super-utilizer programs for the Care diligence providers, and arranged for Management division. William Blair, Chicago, IL debt financing. Completed 3 transac- Healthcare Investment Banking Associate, tions: 1 platform investment, 1 exit, Doctors for Global Health, Morazán, 2015-2016 and 1 add-on acquisition. Monitored El Salvador Healthcare Investment Banking Analyst, 3 portfolio companies; activities Social Enterprise Consultant, 2012-2013 2012-2015 included board observation, review of Developed a financially sustainable Advised on over 45 M&A and public financial reporting, consideration of computer literacy program for rural equity transactions representing a add-on acquisitions, organizational Salvadoran youth, serving 20 students total value of $7.2B in biopharma and structure, recruiting, corporate strat- in its pilot class. Provided technical medical technology. Directed day-to- egy, and support for strategic and support to a micro-enterprise program day execution of transactions, includ- financial growth objectives. Received providing $400K in loans to 1,200 ing developing extensive go-to-market offer to remain for a 3rd year with clients. Created accounting systems materials, managing deal marketing promotion to Senior Associate. and facilitated strategic planning process, conducting financial analyses for agricultural and woodworking and coordinating due diligence. Oliver Wyman, Chicago, IL cooperatives. Managed junior deal team members Senior Consultant, 2013-2014 across multiple projects and served as Consultant, 2011-2013 Partners in Health, Lima, Peru key liaison with senior management Supported executives at payors and Economic Development Field Supervisor, teams. providers within the healthcare space. 2008-2009 Provided analysis, modeling, deck- Oversaw and advised 20 micro-enter- preparation, and meeting facilitation prises operated by patients with to guide strategic decision-making. tuberculosis. Conducted qualitative and quantitative analysis of the micro-enterprise program comprised of 120 businesses.

12 Ethan H. Haimm Nathan Timothy W. Horvat [email protected] [email protected] University of Pennsylvania, Philadelphia, PA R. Handley, M.D. Princeton University, Princeton, NJ B.A., Summa Cum Laude, Phi Beta Kappa, [email protected] A.B., Anthropology, 2010 Biological Basis of Behavior, 2011 Birmingham-Southern College, Birmingham, AL B.S., Chemistry, B.A., Philosophy, Summa Cum Laude, Phi Beta Kappa, 2008 University of Minnesota Medical School, Minneapolis, MN M.D., Alpha Omega Alpha, 2012

An opportunity to design the policies, An opportunity to transform health care An opportunity to commercialize structures, and strategies that transform delivery through innovative technology innovative health care technology with how patients access and receive health and care models. clinical application to improve opera- care. tional efficiency and health outcomes. University of Pennsylvania Division of GE Ventures, Menlo Park, CA Hematology-Oncology, Philadelphia, PA Amgen, Thousand Oaks, CA Associate Intern, Health Care Investing, Fellow Physician, 2015-present Commerical Leadership Program Intern, Summer 2017 Leading team in development a novel Summer 2017 Evaluated attractiveness of follow-on clinical trial management platform Interned with Amgen’s MBA commer- investment in portfolio company; designed to improve access to and cial training program on a $200M+ prepared investment committee knowledge of clinical trials for clinicians P&L U.S. brand team; initiated quanti- presentation outlining deal terms at Penn Medicine. Providing outpatient tative and qualitative research to eval- and rationale, resulting in committee care and inpatient consultative services uate market size and revenue impact approval to proceed with $5M invest- in solid oncology, liquid oncology, and of a drug side-effect; aligned HCP and ment. Led research within value-based benign hematology at the Abramson DTC marketing strategies to mitigate care and drug development markets Cancer Center, the Hospital of the business risk of side-effect with poten- to define investment theses on high University of Pennsylvania, and the tial upside of $20M-30M. opportunity market segments and Philadelphia Veterans Affairs Hospital. source new deals. Doximity, San Francisco, CA Penn Medicine Center for Cancer Care Marketing and Physician Relations Associate, Manatt Health, New York, NY Innovation, Philadelphia, PA 2013-2016 Manager, 2016 Management Fellow, Summer 2017 Marketing Coordinator, 2012-2013 Consultant, 2014-2015 Defined and prioritized best practices Joined early stage, digital health Collaborated with range of health for reducing unplanned acute care for company as part of its initial market- care organizations (hospital, hospice, cancer patients, creating a strategy for ing team and reported to the CEO and research institute) on strategic plan- the Cancer Center in response to a 30 senior leadership; developed growth ning; performed data analysis and day readmission guarantee for all and engagement strategies targeting current state assessments, set growth patients covered by a large regional all U.S. physicians that contributed to priorities, and developed detailed payer. an increase in membership which implementation plans and financial counts more than 60% of U.S. projections. Partnered with CMS on University of California San Francisco physicians; handled $200K marketing policy research and analysis to help Department of Medicine, San Francisco, CA budget for paid marketing campaigns, states operationalize Affordable Intern and Resident Physician, 2012-2015 tradeshows, and sponsorship opportu- Care Act and streamline Medicaid Led teams of three to five residents, nities; led digital channel marketing enrollment. interns, and medical students. Oversaw that focused on search and social and coordinated clinical care and acquisition campaigns from inception Greater New York Hospital Association taught core medical knowledge on to reporting. (Nexera), New York, NY inpatient services at the San Francisco Consultant, 2013-2014 Veterans Affairs Hospital, San Memorial Sloan-Kettering Cancer Analyst, 2011-2012 Francisco General Hospital, and UCSF Center, New York, NY Achieved over $4M in supply chain Medical Center. Provided outpatient Session Assistant, 2010-2012 savings for hospitals through various continuity care at UCSF’s General Coordinated clinical care team and cost reduction strategies, including Internal Medicine Clinic. Engaged in patient flow for medicine and surgical benchmarking, vendor consolidation, the Health Systems and Leadership oncology clinics; interfaced between capitated pricing, and vendor negotia- Pathway, a program designed to clinical team, EMR, and pharmacy soft- tion. provide resident physicians with the ware while handling patient referrals knowledge, skills, and mentorship and billing, scheduling surgical cases necessary to prepare for leadership and chemotherapy visits, and entering careers in healthcare systems. lab work.

13 Dhruv Jaggia Kishore L. Jayakumar Pankaj S. [email protected] [email protected] Jethwani, M.D. Emory University, Atlanta, GA Carnegie Mellon University, Pittsburgh, PA B.S., Neuroscience and Behavioral Biology, B.S., University Honors, Phi Beta Kappa, [email protected] B.A., Chemistry, 2010 Biological Sciences and Psychology, 2012 Dr. V.M., Government Medical College, Perelman School of Medicine at the University Solapur, India of Pennsylvania, Philadelphia, PA Bachelor of Medicine & Bachelor of Surgery, M.D. Candidate, 2018 2012

An opportunity to combine my An opportunity to leverage my clinical, An opportunity to radically improve operational and financial experience financial, and investigative backgrounds access to quality healthcare by growing and people management skills to drive to improve health care delivery. healthcare services businesses. strategic outcomes in healthcare services. Penn Dermatology, Philadelphia, PA Iora Health, Boston, MA MTS Health Partners, New York, NY Investigator, Summer 2017 Intern, Clinical Performance and Summer Associate, Investment Banking, Analyzed complex Epic dataset of 40K Development, Summer 2017 Summer 2017 consultation orders to assess impact of Improved medication management, Advised buy- and sell-side transactions Penn’s dermatology urgent care clinic potentially saving $1M system-wide for global pharmaceutical companies on access to care. Performed statistical and enhancing drug adherence by building full valuation models, analyses on wait times, determined pa- in complex polychronic patients; conducting company due diligence, tient satisfaction ratings, and identi- conceptualized downstream cost and evaluating clinical trial data. fied most common referring specialties management tool for Market Developed investment thesis on the and diagnoses. Directors to manage capitated costs. workers compensation industry and point-of-views on the telemedicine Wharton Health Care Management Steward Health, Boston, MA and EHR sectors. Department, Philadelphia, PA Intern, Hospital Services Group, Investigator, 2014-2015 Summer 2017 International Business Machines (IBM) Designed 35-item survey using FINRA Worked with 6 hospitals to diagnose Corporation, New York, NY and Vanguard instruments to assess reasons for delayed first-case OR starts. Strategic Partnerships Manager, 2015-2016 financial literacy among U.S. medical Devised a strategy to increase on-time Partner Engagement Manager, 2012-2015 students. Administered survey to 2,800 starts; Piloted strategy in 2 hospitals, Grew the Watson Ecosystem to over students at 7 medical schools. improving on-time starts by 50% in 500 partners by providing partners Managed team to develop and exe- 1 month. with project & product management, cute grounded theory-based coding sales, marketing, communications, protocol for qualitative responses. The Boston Consulting Group, financial modeling, and contracts Analyzed quantitative results using New Delhi, India support. In 2014, led expansion into regression techniques in Stata. Project Consultant, 2014-2016 Europe and trained 60% of all new Revealed low financial literacy and Helped set up a public-sector health- hires. Led technical due diligence curricular deficiencies. Awarded 1st care practice in India. Practice works for four investments made by IBM’s place at American Medical Association with State Governments to improve $100M fund. Rated among top Research Symposium. delivery of care across thousands of 2% of performers from 2012-2015. clinics/hospitals. Worked with India’s Received IBM’s Sales Eminence Award Penn Medicine Center for Evidence- largest state to improve delivery and Manager’s Choice Award. based Practice, Philadelphia, PA of primary care across 2,100 clinics Research Fellow, 2014 targeting 70M citizens. Teach for America – Miami Dade Public Evaluated impact of Penn’s AHRQ Schools Evidence-based Practice Center by ana- The Breakfast Revolution, Mumbai, India High School Teacher, 2010-2012 lyzing internal database of evidence Board Member, 2016 onwards Led instruction for 25 AP Biology and reviews and surveying health system Founder, 2014-2016 150 Honors Biology students each clinical and administrative leaders. Conceptualized enterprise to fight year, resulting in a 500% increase Awarded Health Services and Policy malnutrition in India. Manufactured in AP Biology and 58% increase in Research Fellowship. Demonstrated 7 Indian-FDA approved fortified food Honors Biology pass rates. Recognized potential of hospital evidence-based products. Executed scale-up, distribut- as Rookie Teacher of Year and Claes practice centers to improve decision ing 5M meals to 49K patients, improv- Nobel Educator of Distinction. making. Published findings in Journal ing malnutrition in 70% patients of Hospital Medicine. within 6 months.

14 A. Chase Jones Alexander S. Kain Inna Karyeva [email protected] [email protected] [email protected] University of North Carolina, Chapel Hill, NC Indiana University, Bloomington, IN Carnegie Mellon University, Pittsburgh, PA B.S., Business Administration, 2011 B.S., With Distinction, Finance, 2012 B.S., Marketing, 2012

An opportunity to build and work on An opportunity to lead an SMB within An opportunity to develop and lead effective teams within health care health care services, with a hybrid strategic and operational initiatives management, with responsibility for responsibility for operations, strategy, in health care services to improve the both operations and strategy. and finance. patient and provider experience.

Boston Consulting Group, Atlanta, GA Enclara Healthcare, Philadelphia, PA UnitedHealth Group, Eden Prairie, MN Consultant, Summer 2017 Executive Intern, Spring & Summer 2017 Strategic Initiatives Intern, OptumHealth, Produced a strategic pricing overhaul Worked directly with CEO and CFO to Summer 2017 specific to internet reselling for client, implement processes during extreme Led development of the short-term resulting in a gain of $1.1M in annual growth stage (20% annual EBITDA and long-term business plans for impact on gross margin via analysis on growth). Analyzed departmental KPI’s OptumHealth, a $20B line of business large transactional datasets; collabo- and presented findings to the Board; of UnitedHealth Group with over rated alongside client for workflow resulted in a functional reorganiza- 20 discreet business units; evaluated creation of pricing changes compliant tion. Developed strategic alternatives financial performance of each business with individual customer and contract plan for the Board, guiding future unit and developed a strategic path to negotiations, resulting in a 70% gross outlook for financings, growth, and achieve financial and growth targets. margin increase in first quarter of scaling initiatives. Created driver-based Developed a value-based care strategy implementation. budget model to forecast revenue and for OptumCare, an integrated delivery cost targets; gained sponsor approval. network within OptumHealth, evaluat- Vs. Cancer Foundation, Raleigh, NC ing all assets within each market to Founder & CEO, 2012-2016 Cressey & Company, Chicago, IL build an optimized approach (e.g. Launched and scaled nonprofit organi- Associate, Private Equity, 2014-2016 bundled payments to drive alignment zation with a focus on funding inter- Identified attractive healthcare seg- between specialists and primary care national pediatric oncology research ments, evaluated management teams/ providers). and childhood-specific programming core operations, and presented within children’s hospitals via a fund- investment opportunities to senior Evolent Health, Arlington, VA raising platform geared to youth, investment committee; resulted in Associate Program Manager, 2012-2014 collegiate, and professional sporting 6 platform acquisition LOIs. Created Engagement Manager, 2014-2015 teams; raised over $3.2M in 3.5 years financial models and managed teams Associate Director/Chief of Staff, 2015-2016 to become a recognized top-10 of advisors during diligence for new Developed health plan strategy and national childhood cancer funding investments. Completed sale of two operations for health system clients organization based on revenue, portfolio companies (Encompass Home after joining the Payer Strategy and affiliating with 96 children’s hospitals Health – $750M / Hospice Compassus – Operations team as the second across the U.S. while maintaining less $315M). employee. Project work included distri- than a 15% expense ratio. bution channel development, product Lazard, New York, NY and consumer experience strategy, North Carolina Advisory Committee Analyst, TMT Investment Banking, operational improvement projects, on Cancer Coordination and Control, 2012-2014 and strategic growth initiatives. Raleigh, NC Executed M&A transactions, advised Project highlights: (1) analyzed an Board Member, 2013-2016 clients on corporate strategy, and alternative Third Party Administrator Appointed by Office of Governor of pitched for new business. Completed services solution which saved $15M North Carolina to represent statewide four M&A deals in two years, including over 2 years; (2) developed business cancer survivors to collaborate on both buy-side and sell-side engage- case for growth in Managed Medicaid authorship of North Carolina ments. projecting a $200M sales pipeline; (3) Comprehensive Cancer Control redesigned provider negotiation strat- Plan 2014-2020; selected to Policy egy which led to membership growth Committee to unite NC legislation for of 120% by the following year. support in funding cancer prevention and screening.

15 Daniel J. Kennedy John J. Kim Christopher M. Kozak [email protected] [email protected] [email protected] University of North Carolina, Chapel Hill, NC Dartmouth College, Hanover, NH Georgetown University, Washington, DC B.S. and B.A., with Highest Distinction, Business A.B., Magna Cum Laude, Economics, 2010 B.S.B.A., Cum Laude, Finance and International Administration and American History, 2011 Business, 2012

An opportunity to work in a strategy An opportunity to leverage my life An opportunity to identify, build, and or corporate development role for a sciences and consulting backgrounds transform market-leading companies dynamic company leveraging technol- to help develop and commercialize through an equity investment role. ogy to improve health care services. life-changing therapies. Marshall Wace, New York, NY athenahealth, Watertown, MA Genentech, South San Francisco, CA Investment Analysis Intern, Summer 2017 MBA Intern, Summer 2017 Summer Associate, Summer 2017 Identified public equity investment Developed acquisition integration Assessed payer management implica- opportunities in healthcare sector for strategy for an acquired electronic tions of a diagnostic test for a leading global long / short equity medical record provider by performing forecasted $1B+ late-stage pipeline hedge fund manager (part owned by sales and account management pro- product in chronic disease. Managed KKR) with over $30B AUM. Developed cess cross-walks, staffing assessments, internal stakeholders across seven investment theses identifying and best practice reconciliations. different functions and business units dislocations between fundamental Concurrently built a pro forma cost to align on input in payer market equity valuation and consensus analysis that illuminated greater than research, and communicated upside expectations. 50% variance between the 2 organiza- access potential of pipeline product tions. Ultimately presented recom- and diagnostic to senior leadership H.I.G. Capital, Miami, FL mended strategy to athena’s Executive of internal market strategy division. Private Equity Associate, 2014-2016 Team. Evaluated investment opportunities Artisan Healthcare Consulting, across industries for H.I.G.’s largest Evolent Health, Arlington, VA Waltham, MA buyout fund. Developed and executed Associate Director, Corporate Development, Team Leader, 2016 comprehensive due diligence plans. 2015-2016 Senior Consultant, 2014-2016 Managed external teams of financing, Senior Analyst, Corporate Development, Consultant, 2012-2014 legal, consulting, accounting, and tax 2013-2015 Associate, 2010-2012 advisers. Monitored existing portfolio Worked closely with Evolent manage- Strategy consultant for firm’s pharma- company performance and evaluated ment to support capital raising ceutical/biotechnology clients. Project M&A and operational opportunities. process; specifically, constructed work included business development Completed platform acquisition of financial model considering sale ahead opportunity assessments, market ana- synthetic fiber manufacturer (Universal of decision to IPO, and later authored lytics, competitive intelligence, and Fiber Systems), dividend-recapitaliza- sections of the S-1 offering memoran- drug development strategy. Project tion of dental practice management dum and Road Show presentation. highlights: (1) led a team of consul- company (InterDent) and add-on Designed operating partnerships with tants in conducting revenue forecasts acquisitions of 20+ dental offices. hospitals, resulting in 4 deals that of target biotech company’s late-stage Experience with portfolio company contributed over $170M in contracted pipeline assets, resulting in a $1.75B sale process. revenue. acquisition by client, (2) served as strategic partner to U.S. respiratory Credit Suisse, New York, NY SunTrust Robinson Humphrey, division of a pharmaceutical company, M&A Analyst, 2012-2014 Atlanta, GA performing over 30 market analyses Analyzed and executed mergers, Analyst, Health Care Investment Banking, annually for its $1B respiratory acquisitions, divestitures, and lever- 2011-2013 franchise. aged buyouts for corporate clients and As sole Health Care Senior Analyst financial sponsors as Analyst in M&A during second year, completed debt Group. Over $10B in transaction and equity financing raising $10.9B, as experience including 5 closed sale well as 3 mandated M&A transactions. transactions. Received early Associate promotion offer.

16 Vinayak Kumar David J. Li Lorie Lin [email protected] [email protected] [email protected] University of Pennsylvania, Philadelphia, PA University of California, Berkeley; Berkeley, CA Tufts University, Medford, MA B.A., summa cum laude, Biochemistry, 2013 B.S., Business Administration, 2012 B.A., Cum Laude, Quantitative Economics, M.S., Chemistry, 2013 2011 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA M.D. Candidate, 2018

An opportunity to leverage my experi- An opportunity to drive healthcare An opportunity to build and grow a ences in clinical medicine, research, transformation through investments digital innovation strategy to improve and business to improve health care in innovative early-stage businesses. health care delivery. delivery. Pivotal, San Francisco, CA BD (Becton Dickinson), Mountain View, E-Health Now, Philadelphia, PA Product Intern, Summer 2017 CA Co-founder & Clinical Lead, 2016-present Led cross-functional team of software Innovation Hub MBA Intern, Summer 2017 Co-founded E-Health Now at Wharton. developers, support engineers, and Designed business case evaluating Raised $62,000 from angels and accel- marketing associates to develop robotics as a whitespace market erators, built tech platform, forged lower-priced, reduced-feature product development strategy in emerging 10+ partnerships in the U.S. and China offering. Worked with marketing markets. Presented recommendations to recruit patients and doctors, ran teams to understand customer needs for business model innovation to CEO pilot study, initiated patent applica- and identify relative value of product and executive team. Developed proof- tion process, and hired employees. features. Engaged with engineering of-concept prototype of a natural Currently have a potential network of team to evaluate technical feasibility language processing application 800 U.S. oncologists with a population and establish project timelines to for chronic disease management. reach of 3M Chinese patients through prioritize high-value features while partnerships with municipal Chinese removing ones with low-utilization athenahealth, Watertown, MA government, insurance companies, rates and high support costs. Senior Product Innovation Associate, hospitals, and outpatient practices. 2015-2016 Longitude Capital, Menlo Park, CA Product delivery lead driving the Senior Analyst, 2014-2016 development of a cloud-based elec- Center for Medicare and Medicaid Evaluated, executed, and monitored tronic health record (EHR) for hospital Innovation, Baltimore, MD investments for $1.2B venture capital emergency departments from incep- M.D. Intern, Seamless Care Division, fund with a focus on the medical tion to launch. Led designers and Summer 2014 technology and digital health sectors. developers to deliver against product Clinical Researcher, Seamless Care Division, Responsibilities included investment roadmap resulting in successful client 2014-2015 sourcing, due diligence (technical, implementations ahead of schedule. Designed and revised governmental commercial, financial, legal), and programs to improve value-based portfolio company support. Presented Senior Corporate Development Associate, health care delivery. Projects included in-depth investment proposals to 2014-2015 incentivizing collaboration between and participated in all investment Conducted due diligence and executed retail clinics and primary care clinics, committee meetings. two acquisitions that led the compa- revising health policy to allow ny’s expansion into the $900B hospital Accountable Care Organizations Lazard Freres & Co., San Francisco, CA market. Managed a pipeline of 80+ (ACOs) to access Medicare claims Analyst, Healthcare Investment Banking, product and strategic partners to help data for improved care coordination, 2012-2014 drive platform expansion across the and evaluating clinical services for Advised and executed various pharma care continuum. Medicare coverage when designing and biotech M&A transactions, includ- an experimental ACO program. ing Amgen’s $10.4B acquisition of Brown Brothers Harriman & Co., Onyx Pharmaceuticals and Ipsen’s sale Boston, MA of its hemophilia products to Cangene. Associate, 2013-2014 Analyst, 2011-2013 Ran financial and market diligence supporting the execution of $100M+ in senior debt financing for middle- market health service, technology, and medical device companies.

17 Nathan I. Lipkin J.C. Lopez Thomas D. [email protected] [email protected] Magnuson Northwestern University, Evanston, IL Stanford University, Stanford, CA B.S., Journalism, B.A., Economics, 2012 B.S., Biology, 2013 [email protected] Perelman School of Medicine at the University University of Minnesota, Minneapolis, MN of Pennsylvania, Philadelphia, PA B.M.E., Mechanical Engineering, 2009 M.D. Candidate, 2018 M.S., Mechanical Engineering, 2010

An opportunity to build healthcare An opportunity to combine my clinical, An opportunity to build and lead services or technology businesses as scientific, and business expertise to effective teams within health care and an investor or strategy professional. build innovative life sciences companies. health tech consulting in order to help improve quality of patient care. Nuna Health, San Francisco, CA Genentech, South San Francisco, CA Business Development, Summer 2017 Business Development MBA Associate, Bain and Company, Boston, MA Led a long-term strategic planning Summer/Fall 2017 Summer Associate, Summer 2017 process presented to the company, Developed comprehensive landscape Worked alongside team of consultants creating a basis for future product analysis and business development to identify $46M in efficiencies for two roadmaps; analyzed the marginal strategy on the role of artificial merging digital security firms. Built cost of onboarding and maintaining intelligence, big data, and multi-omics executable work plans for 10 business a client based on data for vendor data in the biopharma space. functions detailing redundant contracts, infrastructure usage alloca- Conducted diligence screens and term processes and future methods. Built tions, and employee time; identified sheet negotiations in areas such as revenue upside strategy deck detailing gaps between the current pricing ophthalmology, neuroscience, and future growth sectors for corporate model and the calculated costs; research platforms. Led cross func- strategy group. received high performance ratings tional teams composed of internal from manager. researchers, in-house legal counsel, Medtronic, Minneapolis, MN and finance team members to execute Sr. Research and Development Engineer, GI Partners, San Francisco, CA research collaborations, MTAs, and 2013-2016 Associate, 2014-2016 in-licensing deals. Designed and developed lung tumor Evaluated and managed healthcare biopsy system generating $2M and services and technology investments Militia Hill Ventures, Philadelphia, PA 2 patents in its first year. Streamlined for $2B fund; involved in the full deal Intern, 2016-2017 initial manufacturing activities of sys- process, including idea generation, Analyzed the commercial gene tem reducing device cost by 54% from valuation, comprehensive due therapy landscape that ultimately initial concept. Led technical develop- diligence, and collaboration with influenced the firm to pursue a new ment of novel sensor system used to management. Executed transactions business venture. Developed the busi- identify and navigate directly to lung in the post-acute (Plum Healthcare), ness model for a novel commercial cancer nodules. behavioral health (AdvoServ), and gene therapy entity, which included technology (Logibec, Netsmart primary research, market size analysis, Conventus Orthopaedics, Technologies) sectors. and financing strategy. Screened Minneapolis, MN pre-clinical technologies on the basis Research and Development Engineer, Jefferies, New York, NY of commercial potential and scientific 2010-2013 Analyst, Mergers & Acquisitions, 2012-2014 validity. Led 10 cross-functional product Executed M&A transactions by commercialization projects for custom creating financial models, evaluating Angiio LLC, Philadelphia, PA surgical instruments, including an transaction structures, and performing Co-Founder and CEO, 2015-2016 innovative surgical aid used to fix the due diligence. Directed a team of 3 people to execute position of fracture fragments prior to the company’s R&D, regulatory and IP surgery. Created analytical model for strategy, leading to development of anatomic loading of the wrist based a proof-of concept prototype of a on research of 80+ journal articles. sutureless anastomotic device. Raised over $20K of capital and in-kind services to fund continued develop- ment of the company’s proprietary technology.

18 Clifford M. Marks Julie K. McComish Neel K. Mehta [email protected] [email protected] [email protected] Harvard College, Cambridge, MA Yale University, New Haven, CT University of California, Los Angeles, CA A.B., cum laude, Economics 2010 B.S., Psychology, 2010 B.A., Economics, 2011 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA M.D. Candidate, 2018

An opportunity to meld my clinical skills An opportunity to improve healthcare An opportunity to improve global with health care business knowledge to outcomes through technology, strategy, health through an operational role improve health care delivery systems. and operations focused on wellness and at a growth-stage company. prevention. McKinsey, Philadelphia, PA TOMS, Los Angeles, CA Summer Associate, Summer 2017 DaVita, Denver, CO Business Partner, Summer 2017 Worked for a large commercial insurer Redwoods Summer Associate, Summer 2017 Analyzed industry trends and bench- to identify $500M in annual cost Developed business case for expanding marked company financials against savings as part of an overhaul of the value-based contracting for dialysis those of 6 public competitors. company’s medical management and payments to relationships with small Proposed business model modifica- payment integrity divisions. Project and midsize health insurers. Provided tions to strengthen competitive work included research into novel recommendation on structure of plans advantage, and increase the impact payor strategies, analysis of the and key insurer targets. Built out value and sustainability of charitable dona- financial ramifications, and impact proposition and strategy for landing tions (access to eye care and water). on member experience, presenting to contracts with existing insurance C-suite officers, and advising on imple- partners. Monitor Deloitte, Los Angeles, CA mentation of proposed strategies. Consultant, 2014-2016 Limeade, Bellevue, WA Business Analyst, 2012-2014 Institute for Strategy and Director, Customer Success, 2015-2016 Identified root cause of declining mar- Competitiveness at Harvard Business Account Manager, 2014-2015 gins for health care provider client and School, Boston, MA Managed recurring revenue and cus- developed strategy to reduce $100M Health Care Research Associate, 2012-2013 tomer satisfaction for $6.4M customer operating costs. Created process to Conducted research on health book of business. Led team of 8-17 bring 50K adverse event reports into outcomes measurement and bundled customer success professionals respon- FDA compliance for biotech client. payments at Professor Michael Porter’s sible for managing the strategy and Developed analytics tool for Deloitte Institute for Strategy and Competi tive- execution of wellness programs and managing partners to track internal ness. In addition, I helped launch the building strong customer relationships. sales cycle performance. Supervised International Consortium for Health and mentored 3 analysts and team Outcomes Measurement, a non-profit Microsoft, Redmond, WA (On-site of 25 contractors. devoted to fostering greater use of consultant through Allyis Consulting) outcome measurement in health care Program Manager, Channel Incentives Bank of America Merrill Lynch, through the creation of standardized Strategy Team, 2012-2014 New York, NY sets of outcome measures. Business Analyst, Channel Incentives Analyst, Summer 2011 Strategy Team, 2011-2012 Built financial models and drafted National Journal, Washington, DC Provided strategy, design, and imple- offering memoranda for 5 live deals Economic Policy Reporter, 2010-2011 mentation support for global OEM to assist clients in raising capital for At National Journal, a leading politics Marketing incentive programs paying leveraged buyouts, recapitalizations, and policy publication, I covered a va- out ~$2B per year to multi-national, and refinancings. riety of topics, including the federal distributor, and reseller channels budget, housing, the Federal Reserve, covering Windows Client, Office, and and U.S. job training programs for the Server products. Journal’s website, daily paper, and weekly magazine. In addition, I was Wunderman, Seattle, WA selected to serve on a small task force Associate Account Executive, 2010-2011 formed by the company’s top leader- Managed Microsoft’s Mid-Market ship to chart the publication’s strategy Relationship Program including and competitive positioning. planning, budgeting, executing, and reporting for 73 monthly email and direct mail communications.

19 Lauren E. Miller Michael Mitchell Joshua E. Moore [email protected] [email protected] [email protected] University of Pittsburgh, Pittsburgh, PA University of North Carolina, Chapel Hill, NC Washington University, St. Louis, MO B.S., Summa Cum Laude, Neuroscience, 2013 B.S.B.A., Business Administration 2011 B.A., Honors, Economics, 2011 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA M.D. Candidate, 2018

An opportunity to integrate my An opportunity to drive the growth and An opportunity to advise and build com- biomedical and business experiences strategy of privately-backed, transfor- panies at the crossroads of healthcare, to promote innovation in surgery. mative healthcare services companies in information technology, and finance. a private equity role or as an operator. SR One, Cambridge, MA Moelis and Company, Los Angeles, CA Biotech Venture Capital Intern, Doximity, San Francisco, CA Summer Associate, Investment Banking, Summer 2017 Summer Business Development MBA Intern, Summer 2017 Screened incoming deal flow and Summer 2017 Conducted financial analysis, due conducted investment due diligence. Worked with founders and manage- diligence, and M&A focused materials Performed financial and strategic ment team on strategic projects, development across clients in the tech- analyses on publicly traded portfolio analyzing and creating reports on user nology, media, and consumer sectors. companies. Assessed the investment engagement, developing a monetiza- Analyzed strategies and tactics of challenges and opportunities in the tion framework for product generat- numerous activist investors and devel- epilepsy space. ing >10% of user engagement, and oped relevant client presentation pitched three potential partnership materials. Managed two summer Intersect ENT, Menlo Park, CA opportunities to senior leadership to analysts to conduct valuation exercises, Clinical Affairs Summer Associate, enter new product lines. analyze industry trends, and develop Summer 2016 proposal for hypothetical buy-side Analyzed pivotal data from 2 clinical Enhanced Equity Funds, New York, NY transaction in the food and beverage trials and wrote drafts of associated Private Equity Senior Associate, 2016 industry. manuscripts for publication. Created Private Equity Associate, 2013-2014 an iterative template for internal Evaluated investment opportunities International Business Machines, white papers to use with FDA device and portfolio company strategy at New York City, NY complaint handling. Assessed natural healthcare services private equity Managing Consultant, 2015-2016 history and market strategy for chronic firm with $600M under management. Senior Consultant, 2013-2015 rhinosinusitis. Partnered with portfolio companies Consultant, 2011-2013 to coordinate due diligence, deal Implemented healthcare informatics Penn Center for Innovation execution, and refinancing processes services to modernize one of the Technology Transfer Fellow, 2014-2016 related to add-on acquisitions. nation’s largest healthcare delivery Performed weekly invention assess- Supported executive teams in budget- systems, serving millions of patients ments from a technical, commercial, ing, strategic planning, and capital annually. Drafted white paper that and intellectual property perspective structure decisions. provided the high-level design for to help steer potential licensing Team IBM’s solution. Delivered under and launch new ventures of further Cain Brothers & Company, budget and secured follow-on oppor- development for the University of New York, NY tunity worth $10M. Performed Risk Pennsylvania. Constructed non- Investment Banking Analyst, 2012-2013 Management for multi-vendor, 200+ confidential summaries to assist Executed middle market leveraged FTE healthcare payer implementation, with commercialization strategy buyouts, private capital raises, and specialized in conflict resolution and development. strategic mergers and acquisitions negotiations. Identified contractual, across the health care services operational, and regulatory risks. continuum. Proposed and executed mitigation and recovery plans resulting in cost Raymond James (formerly Morgan avoidance of over $2.3M. Keegan), Atlanta, GA Investment Banking Analyst, 2011-2012 Executed middle market leveraged buyouts, private debt capital raises, and strategic mergers and acquisitions across healthcare, consumer, and financial services industries.

20 Smita Mukherjee, Brent L. Muller Thiri S. Myint [email protected] [email protected] Ph.D. Yale University, New Haven, CT National University of Singapore, Singapore [email protected] B.S., Chemistry, with honors, 2011 B.B.A., Honors, Business Administration, 2011 Hood College, Frederick, MD HEC Paris, France B.A., Biochemistry, 2004 MSc., Honors, Finance, 2014 University of Pennsylvania, Philadelphia, PA Ph.D., Chemistry, 2009

An opportunity to work in an An opportunity to build effective teams An opportunity to work in an invest- operational and/or strategic role that work to improve people’s quality ment or operational role for healthcare in the biopharmaceutical industry. and length of life, with responsibility services and technology sector. for both operations and strategy. Novartis AG, East Hanover, NJ Morgan Stanley, Singapore and Leadership Development Program MBA DaVita Healthcare Partners, Denver, CO Hong Kong Summer Associate, Summer 2017 Redwoods Summer Intern (Integrated Kidney Investment Banking, Summer 2017 Launched an advanced metastatic Care), Summer 2017 Executed 3 live deals (two M&A and breast cancer drug as part of the Identified and presented opportunities one Private Placement) with transac- brand strategy, pricing, and market to General Manager to improve qual- tion value of $1.6B in TMT sector. access teams; led implementation of ity of care and reduce annual medical patient support program, developed costs by $300K for a population of Oliver Wyman, Singapore and strategies and content for DTC patients with End-Stage Renal Disease. Philadelphia, PA marketing, and analyzed sales data Analyzed claims data to identify and Healthcare Consulting, Summer 2017 to optimize salesforce. Independently prioritize medical cost opportunities. Conducted commercial and financial developed health economics based Conducted interviews with internal due diligence of a U.S. Hospital lifetime value proposition of a revolu- stakeholders across functions to iden- ($160M in revenue) for a global tionary drug for people with CML. tify best practices for addressing the private equity firm. Engaged in a opportunities. Developed new report- market study on opportunities in Gerson Lehrman Group, ing processes and tactical plans aimed healthcare for an emerging market. New York City, NY at improving transportation options to Associate Content Manager, dialysis appointments and reducing Singapore Telecom Group, Singapore Healthcare, 2015 hospital readmissions. Senior Manager, Strategy, 2015-2016 Identified emerging trends in health- Manager, Operations Transformation, 2015 care industry to determine relevant Oliver Wyman (formerly OC&C Strategy Led 6-member team to assess market catalysts in the stock market for clients Consultants), Boston, MA potential in Indonesia, Philippines at top investment firms. Concep- Associate, 2015-2016 and Japan that led to investments of tualized and hosted premier events Consultant, 2013-2014 $300M. Facilitated partnership with connecting investor clients with key Associate Consultant, 2012-2013 a U.S. video platform to deliver opinion leaders and top industry Led teams of consultants on projects in telemedicine in Singapore as part executives. Strategized with business the healthcare software, services, and of Project Management Office. development and research teams to information industries. Selected proj- acquire and retain clients. ect experience: (1) conducted the com- Asia Pacific Capital, Singapore mercial diligence of a $50M publisher and Myanmar Harlem Biospace, New York City, NY of healthcare and workplace compli- Senior Investment Analyst, 2012-2013 Associate, 2013-2014 ance content, and identified financial Investment Analyst, 2011-2012 Fellow, 2016 red flags that led the client to discon- Directed team of 5 analysts to conduct Led efforts in creating strategic part- tinue the deal; and (2) developed a due diligence for investments in nerships between member companies portfolio rationalization strategy for healthcare ($20M) and private educa- and pharma companies. Conducted a life sciences information company, tion ($15M). Analyzed 300+ invest- in-depth research on 15 therapeutic resulting in the client merging or ment opportunities: financial models, areas for assessing commercial discontinuing ~20 of 80 product lines. valuation, sensitivity, and return potential for a platform technology. analysis of companies. Organized and moderated expert The Lucas Group, Boston, MA speaker series on entrepreneurship. Associate Consultant, 2011-2012 Conducted cost and quality analysis to support a southern state’s Medicaid reform.

21 Ashley Nguyen Meagan L. O’Kane Joshua S. Ostler [email protected] [email protected] [email protected] University of California, Berkeley, Berkeley, CA Rutgers, The State University of New Jersey, Brigham Young University, Provo, UT B.A., Honors, Economics, 2011 New Brunswick, NJ B.A., Cum Laude, Communications, 2012 B.S., Magna Cum Laude, Biomedical Engineering, 2011

An opportunity to develop and An opportunity to develop and An opportunity to lead within a execute innovative strategies that commercialize innovative therapies for mission-driven healthcare services bring life-saving medicines and health patients with significant unmet needs. company with interest in innovative care services to patients. healthcare provider groups or systems. Celgene Corporation, Summit, NJ Genentech / Roche, Global Marketing Summer Associate, Strategy& (Part of the PwC Network), South San Francisco, CA Summer 2017 New York, NY Global Product Strategy (GPS) Evaluated commercial viability of Summer Senior Associate, Summer 2017 Summer Associate, Summer 2017 Irritable Bowel Disease (IBD) patient Served a regional health insurance Designed and launched qualitative segmentation for lead asset and plan identifying ~$90M in administra- research to develop patient segmenta- presented recommendation to senior tive cost savings opportunities. Led tion strategy for Phase III immunology leadership. Assessed IBD patient efforts on several key workstreams, molecule by managing 2 vendors, support competitive landscape and including member/provider call center conducting market research, and lever- conducted market research to design services, claims, and contingent labor aging insights to define hypotheses for assistance program applicable across analysis. Built projected savings models testing in quantitative phase. Co-led 3 brands. Directed creative and media and constructed prioritization frame- workshop in collaboration with the agencies, in collaboration with con- work to support initial hypotheses Wharton School and GPS University to sumer, clinical and legal, to execute on opportunity size and potential align and engage +25 cross-functional pre-launch initiatives toward achieve- implementation sequencing approach. team members in segmentation ap- ment of critical corporate milestones. proach, process, and research strategy. The Ensign Group (Seaport Home Celgene Cellular Therapeutics, Health & Hospice), San Diego, CA Clinton Health Access Initiative, Warren, NJ Executive Director, 2014-2016 New York, NY Bioengineer I, 2014-2016 Led acquisition, turnaround strategy, Manager, 2016 Associate Bioengineer II, 2012-2014 and ongoing management of a Analyst, Associate, Senior Associate, Associate Bioengineer I, 2011-2012 Medicare certified home health care 2013-2015 Selected as a technical lead on $100M division. Held full financial and gen- Increased efficiency of family planning external collaboration around eral management responsibility for all projects across 69 low-income coun- Chimeric Antigen Receptor T-Cell departments. Introduced an organiza- tries by spearheading market analytics technology. Granted Celgene’s “Living tional vision, culture, and processes initiatives. Formed strategic relation- Our Values” award for extracurricular that resulted in a return to profitabil- ships with +30 private, public, and activities assisting business develop- ity the first month under ownership, non-profit organizations to implement ment. Co-led commercial assessment 100% revenue growth in the first year, family planning strategy that supporting internal development of and significantly enhanced employee increased access to reproductive health cancer immunotherapy valued at satisfaction. services and products for women $215M. Conducted market assessment and girls. of life cycle alternatives for lead cell Goldman Sachs & Co., Los Angeles, CA therapy resulting in selection and clini- Financial Analyst, 2012-2014 Charles River Associates, Oakland, CA cal development of Diabetic Peripheral Key member of one of the firm’s top Associate 2012-2013 Neuropathy for PDA-002. Directed 5 largest teams managing ~$11B of Analyst 2011-2012 cross-functional data audit of client assets in complex portfolios. Generated competitive market Investigational New Drug application analyses and quantitative models gaining FDA approval to initiate Phase for collusion and pricing using I clinical trial. transactional, financial, and public data through Excel and STATA for various industries including semicon- ductors, hospitals, and airlines.

22 Mohona Paul Coby Powers Roya Rashtchi [email protected] [email protected] [email protected] University of Pennsylvania, Philadelphia, PA University of Southern California, Huntsman Program & The Wharton School, B.S.E., Bioengineering, 2011 Los Angeles, CA University of Pennsylvania, Philadelphia, PA University of Pennsylvania, Philadelphia, PA B.S., Electrical Engineering, 2010 B.S., Finance, Operations and Information M.S.E., Bioengineering, 2012 Management, 2011 B.A., International Studies, 2011

An opportunity to drive innovation An opportunity to be a private-equity An opportunity to build and work on ef- and growth in healthcare companies or public-markets investor. fective teams within healthcare services, through strategic and operational work. with responsibility for operations and Fidelity Investments, Boston, MA strategy. Oxeon Partners, New York, NY MBA Equity Analyst, Summer 2017 MBA Summer Intern, Summer 2017 Covered Texas banks (CFR, PB, BOKF, Robin Care, Philadelphia, PA Led development of business case CMA, TCBI). Conducted fundamental Co-founder, Summer 2017-Present for creation of a new venture in the research and interfaced with manage- Developing platform that connects assisted living space; estimated target ment teams of regional banks with families with childcare providers who market size, projected a viable market capitalizations of $4B-$13B. are trained in child development and revenue model and recommended Developed investment recommenda- healthcare. an operations strategy to create the tions and pitched ideas to portfolio business proposal for the venture. managers. Recommendations led to Bain & Company, Los Angeles, CA Supported due diligence for invest- >$150M of investment action (i.e. buys Consultant, 2015-2016 ment opportunities in healthcare tech- and sells). Presented industry review Senior Associate Consultant, 2014-2015 nology startups by evaluating factors recommending conservative under- Associate Consultant, 2012-2014 such as financial performance, writers with superb deposit franchises Earned highest rating on all reviews. customer acquisition strategy, to >75 members of investment team. Developed and presented Bain per- and product maturity/roadmap. Received return offer. spective on healthcare landscape to COOs. Case highlights: (1) Led hybrid IBM Watson Health, New York, NY Francisco Partners, San Francisco, CA Bain-client teams to identify and man- Managing Consultant, 2016 Private Equity Associate w/ $11B Technology age initiatives to reduce PharmaCo’s Senior Consultant, 2014-2016 Private Equity Firm, 2014-2016 R&D cycle time by 18 months, (2) Consultant, 2014 Conducted deep fundamental analyses Facilitated workshops to address Developed and implemented the across the technology sector, including challenges in Biotech’s Process go-to-market strategy for IBM’s cogni- healthcare IT and enterprise software. Development organization, leading tive computing technology. Helped Evaluated both late-stage / value and to ~$800M in reduced spend, (3) create value proposition, customer growth-stage leveraged buyout and Developed case for use of genetic, acquisition strategy, pricing strategy, structured equity investment opportu- epidemiological and EMR data to and product roadmap strategy to nities. Closed leveraged buyout and enhance drugs’ clinical value. enable successful penetration in the subsequent add-on / recapitalization life science and healthcare services of eSolutions, a provider of SaaS reve- Quintiles, Durham, NC markets. Subsequently focused on nue-cycle management products to Manager, Strategy, 2015 growth strategy efforts to scale IBM’s post-acute facilities. Developed mobile health strategies presence in these markets. Proposed with CTO to enhance clinical trials. partnership strategy for specific Health Evolution Partners, San Francisco, Established case for remote monitor- healthcare services-focused products CA ing to decrease trial costs by ~20%. and co-led creation of a successful Private Equity Associate w/ $700M Health- Identified acquisition targets. $40M+ business proposal for a joint care Private Equity Firm, 2013-2014 commercial venture with a top 20 Evaluated companies and led deal pro- Bank of America Merrill Lynch global pharmaceutical company. cesses in health IT and services sectors, Analyst, Financial Sponsors Investment including laboratory IT and hospice Banking, 2011-2012 IBM Global Business Services, businesses. Executed LBO, M&A, and debt New York, NY transactions. Consultant, 2012-2014 J.P. Morgan Securities, San Francisco, CA Strategy consultant with experience Analyst, Healthcare Investment Banking, across the life science industry. Projects 2011-2013 spanned corporate strategy and Performed financial modeling and ran culture change, innovation-focused processes in pharma, biotech, and transformation, and operations medtech sectors. Closed over 10 M&A / transformation strategy. equity transactions. 23 Amanda E. Robison Amrita Sehgal Anita Sekar [email protected] [email protected] [email protected] Duke University, Durham, NC University of California at Berkeley, Brown University, Providence, RI B.S.E., Biomechanical Engineering 2011 Berkeley, CA A.B., Magna Cum Laude, Economics, 2010 B.A., Economics, 2013 University of California Alumni Leadership Award, 2013

An opportunity to work with teams that An opportunity to influence the A business development or strategic utilize data and analytics to improve the management of post-acute care and role at a company developing an quality and cost of health care delivery. alternative payment models to improve innovative healthcare technology. care delivery for the most vulnerable athenahealth, Watertown, MA populations. Guardant Health, Redwood City, CA Summer MBA Intern, Summer 2017 Biopharma Business Development Intern, Quantified costs to deliver and support naviHealth, Newton, MA Summer 2017 interfaces for all products that athena Product & Business Development Intern, Completed 3 strategic projects evaluat- offers. Based on this assessment, Summer 2017 ing partnership activity in companion proposed a solution that when imple- Post-acute care management company diagnostics, the commercial value of mented will reduce the cost by over that offers transition-management companion diagnostic partnerships, 60% ($5M) in the first-half of 2018. software, takes risk on managing post- and trends in the targeted oncology acute care, and manages bundled pay- drug development pipeline. Assisted McKinsey Healthcare Analytics, ment programs. Business development: in structuring of term sheets, service New York, NY Identified synergies between the four agreements, and other contracts Summer Pre-MBA Intern, Summer 2016 newly merged companies, created for 10+ biopharma collaborations. Overhauled a tool to identify opportu- strategy for integrating sales channels, nities in the Episodes of Care Practice products, etc., and refined sales mate- Careport Health, Boston, MA by working closely with data scientists, rials. Explored opportunity to expand Director of Product Strategy and Operations, developers, clinicians, and end-users transition-management model to 2013-2016 to implement new algorithms and other populations. Product manage- As first employee of digital health improvements, bringing the product ment: Created the business case for startup focused on improving post- up to date. expanding transition management acute transitions, supported successful model to alternate care settings such growth strategy from inception The Advisory Board Company, as outpatient facilities. Led efforts to through acquisition-exit to Allscripts. Washington, DC design products featuring new clinical Launched 3 products and directed 5 Director Data Science R&D (DSR&D), reporting capabilities. Received enterprise software implementations Corporate Strategy, 2015-2016 highest performance bonus at the at top-tier health systems including Associate Director DSR&D, end of the summer. the Cleveland Clinic. Corporate Strategy, 2013-2015 Senior Analyst DSR&D, L.E.K. Consulting, Health Care Practice, Gemini Investors, Wellesley, MA Corporate Strategy, 2012-2013 San Francisco, CA Associate, 2012-2013 Analyst, Corporate Strategy, 2011-2012 Associate Consultant, 2015-2016 Responsible for investment due Forged a corporate Data Science team Associate, 2013-2015 diligence, deal execution, and portfo- responsible for maintenance of all Assessed growth opportunities for a lio company strategy for a lower data resources and relationships, data $100B medical device manufacturer; middle market private equity fund. strategy, and creation of predictive developed market size for each oppor- Investment experience in healthcare models as well as analytics. Generated tunity; recommended acquisitions that services and a variety of other sectors. several new SaaS products/features for would further reach in post-acute hospitals, including one with $1.6M in space – client acquired recommended The Lucas Group, Boston, MA sales in 2016 and projected at $150M target for $300M. Evaluated the Senior Associate Consultant, 2012-2012 within 3 years. Arizona Medicare Advantage (MA) Associate Consultant, 2010-2011 and Exchange market for a plan look- Provided investment due diligence for ing to enter; built two market models; large cap and middle market private conducted interviews with health plan equity firms. Worked with a Fortune executives to collect inputs on opera- 500 company on international tional costs and built pro forma finan- expansion strategy. cial statements. Received top score (5/5) on four of five summary reviews and offered full business school sponsorship. 24 Mili Shah Zachary Sheinman Vik Srinivasan [email protected] [email protected] [email protected] Emory University, Atlanta, GA Duke University, Durham, NC Duke University, Durham, NC B.B.A., Finance and Management, 2011 B.S., Economics, 2011 B.A., Magna Cum Laude, Political Science, 2010

An opportunity to build or invest in An opportunity to invest in, partner An opportunity to launch and scale innovative healthcare services and with, and help build health care services products, services, and operating technology businesses focused on organizations. models that improve the quality women’s health. and accessibility of patient care. Axia Women’s Health, Voorhees, NJ Comcast/NBCUniversal, Philadelphia, PA MBA Intern, Summer 2017 Verb Surgical, Mountain View, CA Product Management MBA Intern Worked closely with management and Marketing Intern, Summer 2017 (Strategic Development – Connected Health), sponsor owners (Audax Private Equity) Partnered with 12+ executives to Summer 2017 to execute on accretive acquisitions define customer value proposition, Led development of in-depth product of physician practices and organic create ROI model to support commer- strategy for Comcast’s entry into the initiatives to diversify ancillary service cialization. Led initiative to assess healthcare industry. Created user re- capabilities. Constructed sophisticated product-market fit, prioritize unmet search guides and facilitated ideation KPI dashboard to track key metrics. needs; findings presented to board, sessions and stakeholder interviews Collaborated with CFO to implement guiding subsequent product develop- to assess needs and opportunities. new physician compensation calcula- ment. Advanced 6 projects across Proposed $400M+ new product tion and communicate Q2 compensa- customer segmentation, evidence opportunity, including market-sizing tion to physicians. strategy, people operations, and analysis, go-to-market plan, and global go-to-market strategy. product requirements and roadmap. The Carlyle Group | AlpInvest Partners, New York, NY Advisory Board Company Associate, Private Equity Co-Investments, Consultant, 2015-2016 Everyday Health, Inc., New York, NY 2013-2016 Senior Analyst, 2014-2015 Director, Corporate Development, Member of global 24-person team Analyst, 2013-2014 2014-2016 with ~$10B of assets under manage- Turned around consulting vertical with Developed and implemented ment focused on direct private equity 80% attrition rate. Aided development recommendations regarding M&A, co-investments in leveraged buyout, and launch of 2 new consulting partnerships and corporate strategy. middle market and growth equity verticals focused on telemedicine and Performed due diligence and deal transactions across all industries. Led outpatient services. Directed projects execution, including valuation and business due diligence, built financial named as finalists (top 12) in consecu- deal structure proposals and purchase models to evaluate returns, and tive years of firm’s annual client agreement negotiations. Led ~$150M prepared investment committee impact competition. Scoped and of acquisitions and drove post- materials. Collaborated with Investor managed 60+ engagements, 15-20 acquisition integration and strategic Relations to help coordinate fund- concurrently, for provider organiza- planning. raising as team’s junior point person tions in the U.S. and internationally. globally. Interviewed hundreds of hospital Piper Jaffray & Company, New York, NY executives to distill best practices. Associate, Healthcare Investment Banking, Jefferies, LLC 2013 Analyst, Healthcare Investment Banking, U.S. House Congressional Campaign Analyst, Healthcare Investment Banking, 2011-2013 Committee 2011-2013 Advised various healthcare services Deputy Director of Strategic Initiatives / Advised global healthcare companies and life sciences companies on strate- Rapid Response Coordinator, 2011-2013 on M&A, leveraged buy-outs and gic M&A and capital markets financ- Drafted responses to breaking policy public and private capital raises. ings (debt & equity), facilitating news circulated daily to Members Ranked as top-tier analyst in each transaction processes, building finan- of Congress and the press, driving annual performance review and cial models, and preparing valuation national and local media coverage. promoted to associate after two years. analyses. Co-launched Jefferies’ first recruiting initiative at Duke University.

25 Cecilia Sun Matthew C. Sweeney Joshua M. Talbot [email protected] [email protected] [email protected] University of Pennsylvania, Philadelphia, PA Indiana University, Bloomington, IN University of Virginia, Charlottesville, VA B.A., Summa Cum Laude, with Distinction, B.S., Finance and Accounting, 2009 B.S., Summa Cum Laude, Systems Engineering, Biology, 2012 B.A., Summa Cum Laude, Economics, 2013 B.S., Summa Cum Laude, Economics, 2012

An opportunity to build and grow An opportunity to identify and build An opportunity to advance the biotechnology companies discovering successful healthcare businesses intersection of medicine and emerging and developing innovative through a private equity investing role. technologies (digital health, IoT, block- new medicines. chain) for improved health outcomes. Shore Capital Partners, Chicago, IL Genentech, South San Francisco, CA MBA Intern, Summer 2017 Mckinsey and Company, Charlotte, NC Business Development Summer Associate, Evaluated middle-market, private Summer Associate, Summer 2017 Summer 2017 equity investment opportunities in the Led clinical operations analytics work- Led 20-person team on design of healthcare sector. Executed platform stream yielding $6M in savings for microbiome research study; executed investment of an urgent care company large, regional health system. Created CDA and drafted term sheet. and add-on investment of a wound and led 150-page thought leadership Evaluated Phase II small molecule care products company. Completed response to BCRA and AHCA policy and presented findings to portfolio initial 100-day plan including budget, used by over three dozen client teams. committee; resulted in “go” to full KPI development and financial Supported clinical growth strategy for diligence. Screened over 2,000 cancer reporting package for autism services large, national health system. programs; Identified 27 new cancer portfolio company. Developed and targets for future research or partner- presented a thesis for investment in Deloitte Consulting, Arlington, VA ing. Performed analysis of 3 oncology the long-term care ancillary services Technology Consultant, Business Technology deal contracts; presented takeaways sector. Analyst, Summer Scholar, 2012-2016 to senior leadership. Healthcare Business Analytics and Modeling Enhanced Equity Funds, New York, NY Served as Certified Scrumaster on Aisling Capital, New York, NY Senior Associate, 2015-2016 multi-year modernization for big data Venture Capital Analyst, 2014- 2016 Associate, 2013-2015 drug analytics. Co-led drug supply Served on investment team that man- Evaluated investment opportunities chain data analytics and financial aged $1.8B AUM and evaluated 700- at healthcare services focused private modeling enhancements to reduce 800 new opportunities annually across equity firm with $600M under review period for pre-market drugs biotech, pharma, medtech, and health- management. Executed platform from 18 to 12 months. Intra preneur- care services. Led scientific, clinical, investments as well as several add-on ship and Business Development: regulatory, financial, and commercial investments in the dermatology and Spearheaded internal startup using diligence. Diligence process included: medical transportation sectors. wearables data, blockchain technol- interacting 1x1 with management Worked with portfolio companies ogy, and predictive analytics to create teams, interviewing KOLs, attending and supported management teams a smart patient intelligence platform. medical and investor conferences, and in budgeting, strategic planning, Created and led innovation group to reading scientific publications. and capital structure decisions. help foster a culture of innovation across the 500 Business Technology Credit Suisse, New York, NY Houlihan Lokey, Chicago, IL Analysts (BTAs), exposing BTAs to Investment Banking Analyst, 2012- 2014 Analyst, Healthcare Investment Banking, thought leadership, agile practices, Ranked AAA analyst: top 10% of 2011-2013 and Design Thinking. Social Impact: investment banking analyst class. Advised middle market mergers and Represented Deloitte at the IMF and Completed over dozen lead-left trans- acquisitions for a variety of healthcare World Bank’s African Youth Forum actions, raising several billion dollars in services companies. (AYF) in Cote d’Ivoire. Led 2-3 high yield and leveraged loan markets. delegates from each African country Deloitte, Chicago, IL through targeted workshops to ad- Associate, Transaction Advisory Services, dress challenges in health, entrepre- 2010-2011 neurship, and education. Created Advised clients in matters of quality annual STEM workshops with 200 of earnings analyses, purchase price Deloitte practitioners and 475 DC allocations and goodwill impairment students. testing.

26 Kengo Tashiro, M.D. Allison E. Toman John Xavier R. [email protected] [email protected] Valdes Fulbright Scholar, 2016-2018 University of Chicago, Chicago, IL Kamiyama Scholar, 2016- A.B., History and International Studies [email protected] Harvard Medical School (double major), 2009 Ateneo de Manila University, Primary Care Internal Medicine Program, 2012 Quezon City, Philippines Kyoto University, Japan B.S., Health Sciences, 2013 Medical Doctorate, 2011

Establish a new health care provider A business development or operations An opportunity to improve healthcare model that is faster, cheaper, safer, role at an innovative, mission-driven access in developing countries through and better. company focused on improving care a commercial role in a pharmaceutical delivery. or biotechnology company. DaVita Inc. Redwoods Summer Associate, 2017 Medtronic, Minneapolis, MN Gilead Sciences, Foster City, CA Designed and introduced a new cloud- Corporate Strategy (Globalization), MBA Intern – Direct to Patient HIV based Enterprise Resource Planning Summer 2017 Marketing, Summer 2017 (ERP) system to the company’s 100+ Led development of comprehensive Designed study on HIV treatment Asia Pacific dialysis centers. product, services, and market strate- choice during patient-provider conver- gies for integrated delivery systems in sations. Updated unbranded promo- Boston Consulting Group, Tokyo emerging markets; ideated, designed, tional assets and paid search strategy Summer Associate, 2017 and piloted time-driven activity-based for Promotional Review Committee Made strategic proposal for a $100M costing solution for a large hospital approval. Analyzed competitors’ turnaround of a major hospital in system in Hyderabad, India to auto- DTP marketing materials and Tokyo, identifying growth opportuni- mate the identification of process effi- recommended tactics for adoption. ties and defining quality index to ciencies and cost saving opportunities improve/publish clinical performances. across clinical pathways; formulated EpiMetrics Inc, Paranaque City, five-year plan for transforming costing Philippines Global Collaboration Center for Drugs, platform into SaaS-based solution with Co-Founder and Researcher, 2015-2017 Devices and Healthcare/IT $1B+ global market opportunity. Developed the Philippines’ first list Co-Founding-Member & of priority diseases for guaranteed Chief-Medical-Officer, 2013-2016 HealthScape Advisors, Chicago, IL coverage by the national health Co-founded a public-private technol- Manager, 2015-2016 insurance program (NHIP). Led budget ogy incubator to accelerate develop- Senior Consultant, 2012-2014 impact modeling for 31 candidate ment and global export of innovative Consultant, 2009-2012 treatments for NHIP coverage. health care technologies for 18 mem- Directed health plan in the develop- Managed nationwide data collection bers including KonicaMinolta, Hitachi, ment of value-based partnerships with in 196 municipalities. Organized Fujifilm, Mitsubishi & NTT Groups, and six major health systems and designed 22-person team to execute 8-week Sony, as well as venture companies. clinical strategies to save $50M in year research training for Department one. Directed health plan in RFP pro- of Health staff. Ministry of Health, Welfare and Labor, curement process, evaluation, and se- Seconded to Kanagawa Prefecture lection of its new dental managed care Energy Development Corporation, Government vendor, resulting in revenue growth of Pasig City, Philippines First Class Officer, Healthcare Policy 15% and margin improvement of 2% International Business Development Analyst, Assistant to the Governor, 2013-2016 year-over-year. Advised leading global 2013-2015 Assisted the governor of the largest private equity firm on the acquisition Modeled 25-year returns for flagship state in Japan in establishing a of a behavioral health company, creat- project in Chile; projections resulted Healthcare-Industrial-Special-Zone, ing the largest stand-alone behavioral in $18M in funding from a multilateral and driving population health health management company in the lender and board approval for $30M management initiatives. United States. drilling phase. Led cross functional team from 4 countries to convert Kitano Hospital & Research Institute Chilean geothermal site to exploita- Medical Resident in Surgery, 2011-2013 tion status. Conducted due diligence Voted best-resident-of-the-year, for EDC’s $3M acquisition of HRL. dispatched on scholarship to study at Harvard Medical School. Japanese Society of Gastroenterological Surgery Residents Distinguished Presentation Award.

27 Dhruve Vasishtha David T. Wilkinson Jonathan K. Wood [email protected] [email protected] [email protected] Columbia University, New York, NY Wake Forest University, Winston-Salem, NC Yale University, New Haven, CT B.A., Economics, 2011 B.S., Magna Cum Laude, Finance, 2010 B.A., Classical Languages and Literatures, 2003 Perelman School of Medicine at the University of Pennsylvania, Philadelphia PA M.D. Candidate, 2018

An opportunity to launch new health- An opportunity to build and lead effec- An opportunity to pioneer hyperlocal care technologies that improve effec- tive teams within medical technology, health care alongside community devel- tiveness of patient care, quality of life, with responsibility for marketing, opment with low income communities. or clinical research. operations, and/or strategy. Viral Hepatitis Center, Johns Hopkins Yeva, Philadelphia, PA Medtronic, San Francisco, CA School of Medicine, Baltimore, MD Founder and CEO, 2017- Leadership Development Rotational Program Clinical Research Coordinator, 2012-2013 Recruited and led CTO, clinicians, and Summer Associate, Summer 2017 Coordinated and co-authored caregivers to design and launch first- Developed and presented coronary NIH-funded study of Interferon-alpha ever personalized caregiver training stent marketing campaign strategy for response among HCV and HIV platform, serving 100 daily users. entry into $410M segment of coronary co-infected patients. Earned $10K in grants. Developed artery disease market. Built market partnerships with health systems sizing model and identified $40M Air Force Special Operations Command executives, home care providers, the of potential market upside. Crafted Unit, Fayetteville, NC Alzheimer’s Association, and AARP. competitive advantage messaging for Director of Intelligence, 2007-2010 Medtronic coronary stent and market- Active duty Air Force officer deployed Medidata, New York, NY ing campaign roadmap. Collaborated as lead of intelligence operations for Product Manager, 2014-2016 with functional groups across sensitive interagency task force target- Led execution of award-winning, first Medtronic; conducted interviews ing regional al Qaida leadership in to market software from ideation to with physicians to understand market complex battlespace. Directed fleet of launch: a patient research app, and needs. 15 aerial and naval assets in dynamic biosensor data platform. Engaged reconnaissance strategy. Briefed end users, internal stakeholders, and Sentinel Capital Partners, Chairman of Joint Chiefs and agency customers from 6 leading pharmacos New York City, NY directors for mission approval. Chaired (GSK, Bayer, J&J) to define product Private Equity Senior Associate, 2014-2016 daily meetings of 75 operatives in 8 specifications for 15 engineers and Private Equity Associate, 2012-2014 locations, synchronizing and focusing designers. Supported business devel- Led all aspects of investment process regional intelligence efforts across opment and account management including screening prospective trans- 5 partner intelligence agencies. to scale revenues from $0 to $5M. actions, managing internal deal teams Awarded Bronze Star and Defense and external advisors, negotiating Meritorious Service Medal. Wellnest, New York, NY legal documents, and securing debt Founder, 2013-2014 financing for private equity firm 320th Special Tactics Squadron, Launched mental health app that de- managing $2.6B in assets. Closed Okinawa, Japan livered on-demand access to clinically- 22 leveraged buyout transactions, Director of Intelligence, 2005-2007 proven anxiety management tools. portfolio company sales, and debt Provided intelligence for 35 warfight- Architected revenue-generating busi- financing deals. ers in 3 combat regions. Deployed as ness model through beta testing with embedded counterinsurgency advisor 50+ licensed therapists and patients. Wells Fargo Securities, Charlotte, NC to Philippine Air Force, conducting Investment Banking Analyst, 2010-2012 intelligence sharing and capacity ZS Associates, New York, NY Executed debt, equity, and M&A building. Deployed to Afghanistan, Business Consulting Associate, 2011-2013 transactions, and competed for conducting threat and terrain analysis Strategy consultant for multinational prospective investment banking for combat search and rescue team, pharmacos. Shaped global launch mandates for middle market compa- safely supporting 40 missions. strategies of six products (revenues nies on 3- to 5-person teams across a of $450M - $1.3B) through combined range of industries. quantitative analyses and qualitative market research. Led client communi- cations, presentations, and workshops.

28 Pratyusha Quingan Zhou Yan Zhou [email protected] [email protected] Yalamanchi Yale University, New Haven, CT Rice University, Houston, TX [email protected] B.A., Cum Laude, Distinction in Major, B.A., Cum Laude, Applied Mathematics, B.A., Harvard University, Cambridge, MA Humanities, 2011 Cum Laude, Economics, 2011 B.A. with High Honors, Magna Cum Laude Human Evolutionary Biology, Secondary in Studio Art, 2013 Perelman School of Medicine at the University of Pennsylvania, Philadelphia PA M.D. Candidate, 2018

An opportunity to combine my clinical An opportunity to build new products A opportunity to improve health and business experiences to improve and services to improve the healthcare care delivery and patient experience health care outcomes. delivery system. through new products, services, and/or operating models. University of Pennsylvania Health University of Pittsburgh Medical Center System (UPHS), Philadelphia, PA Enterprises, Pittsburgh, PA Accenture, New York, NY Chief Medical Office Internship, Product Management Summer Associate, Senior Strategy Consultant, Summer 2017 Summer 2017 Summer 2017 Created 4 post-close divestiture Evaluated 2016-2017 Endocrine/GI Created a business plan for a portfolio separation playbooks and conducted service line readmission encounters to company’s new product focused workshops for a multinational phar- characterize patient profiles, recognize on post-acute care telemedicine; maceutical client through surveying risk factors and contribution margin, presented recommendations to CEO 18 project teams on 16 topics and and identify possible opportunities for on product launch strategies, which discovering themes from feedback intervention. Presented opportunities aimed to double the company’s to inform future M&A efforts. to decrease readmission rates and revenue. Developed a new company increase market share to UPHS focused on supporting caregivers; in- GE Capital, Norwalk, CT executives. terviewed >20 stakeholders, analyzed Economic Capital Risk Analyst, 2014-2016 market needs and trends, and collabo- Led the quarterly economic capital ad- Perelman School of Medicine rated with design researchers and equacy assessment across all businesses at the University of Pennsylvania, software engineers. and simplified processes to reduce Philadelphia, PA time spent from 1.5 months to 3 Department of Otolaryngology, Regal Medical Group, Northridge, CA weeks, saving ~100 hours across 8 Head and Neck Surgery Student Researcher, Chief of Staff & Assistant Administrator teams. Built multi-year capital forecast June 2016-June 2018 of Operations, 2014-2016 as the company shrunk and identified Evaluating the efficacy of dexametha- Senior Project Manager, 2014 areas of opportunity to ensure positive sone eluting stent in murine model of Project Specialist, 2013 capital surplus. subglottic stenosis. Managed 2 departments with 30 employees; redesigned both depart- GE Healthcare, Waukesha, WI Penn Center for Community Health ments’ organizational structures and Financial Management Program (FMP), Workers, Philadelphia, PA performance benchmarks to improve 2012-2014 Student Researcher, June 2014-June 2016 employee productivity. Directed Selected as top 10% of applicants for Launched the IMPaCT Transitions company-wide initiatives with 22 exec- a two-year rotational leadership pro- Quality Improvement project to evalu- utives by determining implementation gram with focus on FP&A, Corporate ate how community health workers strategies and building census. For Strategy, Operational Efficiency, and can support the transition from example, I led 14 departments to Controllership. Recipient of the inpatient discharge to outpatient care, establish new processes and staffing “Outstanding FMP” award as selected leading to greater discharge prescrip- needs for a new product line that by the program executive committee. tion fill rates, and follow-up appoint- resulted in 2% business growth. Key accomplishments: managed sales ment attendance. Developed a to margin financials and met operat- marketing plan, literature, and Prostate Cancer Foundation, Santa ing plan targets for 3 HCIT products managed provider outreach strategy. Monica, CA with $40M quarterly revenue; Leader, PCF China, 2012-2013 simplified the global financial Dental HygIndia, Andhra Pradesh, India Fellow, 2011 closing process by 2 hours daily. Founder, June 2004-June 2014 Launched PCF’s research initiative in Founded 501(c)(3) to establish a free, China by building and managing rela- oral health mobile clinic and raised tionships with 26 global institutes and funds through grants/corporate part- >200 stakeholders. Designed 2 grant nerships with companies like Colgate competitions to provide $525,000 to and Siemens for 200 dental hygiene 5 Chinese scientists. Organized 6 awareness and treatment camps. international conferences.

29 Yisha Zhou [email protected] Zhejiang University, Hangzhou, China B.S., Cum Laude, Geology, 2009

An opportunity to work in a business development or investment role to grow leading health care technology.

Neuberger Berman, Hong Kong, China MBA Summer Equity Analyst, Summer 2017 Performed fundamental analysis on Chinese pharmaceutical industry for $5.3B AUM (Asset Under Management) Asia Equity Fund. Conducted a market overview to eval- uate promising novel cancer therapies. Evaluated new drugs using adjusted DCF and comparable transaction ap- proaches. Conducted detailed research on BGNE and pitched it to investors in Asia and the U.S.

CHC Holdings, Shanghai, China Director, 2015-2016 Manager, 2013-2015 Awarded “Employee of the Year” (1 of 2 selected out of 50) in 2013 with only 6 months tenure for outstanding teamwork and solid analytical skills. Invested $300M in equity across 3 closed transactions after evaluating 30+ investment opportunities. Established hospital M&A team by recruiting talent and equipping team with expertise through trainings.

China Resources, Beijing and Wuhan, China Manager, 2012-2013 Built market analysis, performed financial modeling, and negotiated with local government, leading to 2 public hospital acquisitions with com- bined value of over $150M. Facilitated operational turnaround of portfolio company through right-sizing of oper- ational expenses, and implementing strategic initiatives.

30 2017 Internship Sponsors

The following organizations OBERLAND CAPITAL FIDELITY provided internships for Health Care New York, NY Boston, MA Management Students in Summer, 2017. OLIVER WYMAN GE VENTURES Philadelphia, PA Menlo Park, CA ONCORA MEDICAL GENENTECH Philadelphia, PA ABBVIE, INC. South San Francisco, CA Chicago, IL OXEON PARTNERS GENENTECH / ROCHE New York, NY ACCENTURE South San Francisco, CA New York City, NY PFIZER GILEAD SCIENCES New York, NY ACCOLADE Foster City, CA Plymouth Meeting, PA PIVOTAL GUARDANT HEALTH San Francisco, CA AMGEN Redwood City, CA Thousand Oaks, CA ROBIN CARE HUP/PRESBYTERIAN Philadelphia, PA ATHENAHEALTH Philadelphia, CA Watertown, MA ROCA PARTNERS IORA HEALTH Los Angeles, CA AXIA WOMEN’S HEALTH Boston, MA Voorhees, NJ SANOFI GENZYME MARSHALL WACE Cambridge, MA BAIN AND COMPANY New York, NY Boston, MA SHORE CAPITAL MBF HEALTHCARE PARTNERS Chicago, IL BARCLAYS INVESTMENT BANK Miami, FL New York, NY SR ONE MCKINSEY & COMPANY Boston, MA BD (BECTON DICKINSON) Boston, MA Mountain View, CA Charlotte, NC STEWARD HEALTH CARE Philadelphia, PA Boston, MA THE BOSTON CONSULTING GROUP Atlanta, GA MEDTRONIC STRATEGY& Tokyo San Francisco, CA New York, NY Boulder, CO CELGENE CORPORATION Minneapolis, MN TAILWIND CAPITAL Summit, NJ New York, NY MOELIS & COMPANY CIGNA Los Angeles, CA TOMS Philadelphia, PA Los Angeles, CA MORGAN STANLEY CLEVELAND CLINIC Singapore UNITEDHEALTH GROUP Cleveland, OH Eden Prairie, MN MTS HEALTH PARTNERS COMCAST/NBC UNIVERSAL New York, NY UNIVERSITY OF PENNSYLVANIA Philadelphia, PA HEALTH SYSTEM NAVIHEALTH Penn Dermatology DAVITA HEALTHCARE PARTNERS Boston MA Division of Hematology-Oncology Denver, CO Philadelphia, PA Singapore NEUBERGER BERMAN New York /Hong Kong UNIVERSITY OF PITTSBURG DOXIMITY MEDICAL CENTER ENTERPRISES San Francisco, CA NOVARTIS AG Pittsburgh, PA East Hanover, NJ DW HEALTHCARE PARTNERS VIRAL HEPATITIS CENTER Toronto, Canada NOVARTIS JOHN HOPKINS SCHOOL OF MEDICINE PHARMACEUTICALS CORPORATION Baltimore, MD EHEALTH NOW East Hanover, NJ Philadelphia, PA VERB SURGICAL NOVARTIS ONCOLOGY Mountain View, CA ENCLARA HEALTHCARE East Hanover, NJ Philadelphia, PA YEVA NUNA HEALTH Philadelphia, PA ESPERANZA HEALTH CENTER (FQHC) San Francisco, CA Philadelphia, PA

31 2017 Health Care Program Mentors

Mentors are leaders and senior managers SAURABH BHANSALI THIERRY CHAUCHÉ in the health care field who have agreed to Partner Executive Director, Health Velocity Capital Financial Planning & Analysis provide career and professional development San Francisco, CA Intercept Pharmaceuticals advice and guidance to Health Care New York, NY NIKHIL BHOJWANI Management Students. Managing Partner EILEEN CHEIGH Recon Strategy Vice President Cambridge, MA Pfizer Inc. New York, NY DARREN M. BLACK SANDIP K. AGARWALA Managing Director MARK CHIN Managing Director Summit Partners Investment Manager Longitude Capital Boston, MA Arix Bioscience Greenwich, CT New York, NY SAM BRASCH HEATHER ASPRAS Senior Managing Director YUMING CHIU Director, New Product Strategy, Vaccines Kaiser Permanente Ventures Product Manager, GlaxoSmithKline Oakland, CA HIV Direct to Patient Marketing Philadelphia, PA Gilead Sciences ROB BRESSLER MICHAEL AXT Foster City, CA Business Development Chief Marketing Officer and Senior Vice and Corporate Finance EDDIE CISNEROS President Solutions Development, Teladoc Health Care Consultant/Executive Coach Marketing and Strategy Chicago/New York Inspirate Advisory Services LLC Cotiviti Schaumburg, IL Atlanta, GA STEVEN BRESSLER Vice President CHIP CLARK KENT E. BACKLUND Parthenon Capital Partners Chief Executive Officer Director Boston, MA Genocea Biosciences Pfizer, Inc. Cambridge, MA New York, NY TOM BROD President/Owner JULIA P. COCHRAN VIKRAM BAKHRU North Shores Consulting Inc. Director, Chief Operating Officer Columbus, OH Forecasting & Market Analytics Consejo Sano, Inc. Alkermes North Hollywood, CA KARA BROTEMARKLE Waltham, MA International Business Leader TONY BALDA Roche RYAN COCHRAN President & Chief Executive Officer Basel, Switzerland Founder Medicomp, Inc. Recharge Healthcare, Melbourne, FL LUCAS BUCHANAN Diagram Healthcare Chief Financial Officer JOHN BARBIERI, M.D. New York, NY Silk Road Medical, Inc. Dermatology Resident Sunnyvale, CA BRETT COHEN Hospital of the University of Pennsylvania Chief Operating Officer Philadelphia, PA ELIZABETH J. CAMPBELL Civitas Solutions Principal JAMIL M. BEG Boston, MA LLR Partners Principal Philadelphia, PA ROBB COHEN 5AM Ventures Chief Executive Officer Boston, MA NICOLE CARKNER Advanced Health Collaborative Executive Director ALI BEHBAHANI, M.D. Baltimore, MD Quad City Health Initiative Partner Davenport, IA TERI CONDON New Enterprise Associates Senior Vice President, Client Services Chevy Chase, MD JEFF CHAPMAN Wellframe Partner, SIGAL BEN-ARI, PH.D. Boston, MA Head of Life Science and Healthcare Chief Operating Officer Wellington Financial MICHAEL CRAWFORD Kodu Care Menlo Park, CA Vice President Seattle, WA Health Net Woodland Hills, CA

32 DAVID DENNIS DOUGLAS C. FISHER, M.D. TAEJIN (JUSTIN) HAM Senior Director, Strategy Partner Regional Director of Marketing and Business Development InterWest Healthcare Partners and Strategy Cardinal Health Menlo Park, CA Celgene Dublin, OH Singapore PETER FISHMAN PITAMBER “PITOU” DEVGON, M.D. Director of Clinical Integration JOHN HARROFF President, Co-founder CarePoint Health Vice President Velano Vascular, Inc. Jersey City, NJ H.I.G. Capital Philadelphia, PA New York, NY AARON FLINK BENJAMIN DORANZ, PH.D. Principal DANIEL HARVEY President and Chief Executive Officer Heritage Group Project Leader Integral Molecular, Inc. Nashville, TN The Boston Consulting Group Philadelphia, PA New York, NY J.P. GALLAGHER CASEY DOUGAN Chief Operating Officer JAWAD HASAN Engagement Manager NorthShore University HealthSystem Vice President McKinsey & Co. Evanston, IL Apax Partners San Francisco, CA New York, NY MICHELE A. GALLUCCI J. PATRICK DOUGHERTY Vice President Development & Strategy BOSUN HAU Director of Strategy Medocity, Inc. Managing Director and Partner & Chief of Staff to SVP R&D Pipeline Parsippany, NJ Sailing Capital GlaxoSmithKline (R&D) Hong Kong Collegeville, PA SIMEON J. GEORGE, M.D. Partner BEN HERMAN BRANDON EINSTEIN, M.D. SR One Vice President Vice President San Francisco, CA Cressey & Company LP Enhanced Healthcare Partners Chicago, IL New York, NY SEAN GLEESON, M.D. President LINDSAY HERMAN RAMI ELGHANDOUR Partners For Kids, Program Manager, Strategy President & Chief Executive Officer Nationwide Children’s Hospital Northwestern Medicine Nevro Columbus, OH Chicago, IL Redwood Shores, CA GARY L. GOTTLIEB, M.D. JANE HERZECA JENN ETHERIDGE Chief Executive Officer Head of Markets and Implementation Senior Manager, Patient Insights Partners In Health Quartet Genentech Boston, MA New York, NY San Francisco, CA VIKAS GOYAL VLAD HOGENHUIS, M.D. MYRIAM EXUMÉ Principal Senior Vice President Pharmaceuticals US Marketing Leader, CV Franchise SR One GlaxoSmithKiline Merck Cambridge, MA London, UK North Wales, PA TODD GUREN BRIAN HOLZER, M.D. DANIEL FAGA Director, Product Management President, Kindred Innovations Chief Business Officer Regence BlueCross BlueShield Kindred Healthcare Spark Therapeutics Portland, OR Louisville, KY Philadelphia, PA PHILIP P. GUTRY AMANDA HOPKINS TIRRELL MING FANG Senior Director, Business Development Chief Operating Officer Vice President Regeneron Pharmaceuticals Georgia Regent Medical Associates Redmile Tarrytown, NY Augusta, GA San Francisco, CA T. SLOAN GUY, M.D. VIVIAN HSU MICHAEL FAZEKAS Associate Professor of Program Officer, Vaccine Development Principal Cardiothoracic Surgery Gates Foundation Flexpoint Ford, LLC Weill Cornell Medicine Seattle, WA Chicago, IL New York, NY

33 Health Care Program Mentors

MARY HU ADAM LESSLER, M.D. GRETCHEN MILLS Associate Dean for Communications Vice President Researcher Market Strategy and Chief Communications Officer Canepa Healthcare 3M Health Information Systems Yale University of Medicine New York, NY Denver, CO New Haven, CT BRIAN LEWANDOWSKI SACHIYO MINEGISHI OREN K. ISACOFF Analyst Global Brand Lead, Vice President Tamarack Capital Management Sickle Cell Disease and Oncology Longitude Capital Carlsbad, CA bluebird bio Greenwich, CT Cambridge, MA NANXI LING MUDIT K. JAIN Senior Advisor, J. CARTER MONTAGUE Managing Director Enterprise Product Innovation Chief Operating Officer Synergy Life Science Partners CVS Health Cyft Burlingame, CA Woonsocket, RI Cambridge, MA

VIVEK JAIN JEFFREY S. LITWIN, M.D. REGAN MURPHY Vice President Chief Executive Officer General Manager H.I.G. Capital MedAvante-ProPhase The Governance Institute – NRC Health New York, NY Princeton, NJ Chicago, IL

ANUJ KAPOOR WENDY LIU ASHWIN R. MURTHY Senior Director of Analytics Solutions Senior Director, New Business Case Team Leader Procured Health Pfizer Bain & Company Chicago, IL New York, NY San Francisco, CA

ADAM KAUFMANN CAROLYN MAGILL HAREESH NAIR President & Chief Executive Officer Chief Executive Officer Director Canary Health Remedy Partners Quadria Capital Los Angeles, CA Darien, CT Investment Management Pte Ltd Singapore KARL KELLNER ANKIT A. MAHADEVIA, M.D. Senior Partner Chief Executive Officer PRASHANT NIKAM, PH.D. McKinsey & Company, Inc. Spero Therapeutics Senior Director New York, NY Cambridge, MA Global Brand Team – JAKAVI (Ruxolitinib) Novartis Oncology STEPHEN KIM SAMIR MALIK East Hanover, NJ Vice President Founder Goldman Sachs & Co. Genoa Telepsychiatry WES NURSS Los Angeles & New York New York, NY Analyst Marshall Wace ERIC KLEIN LAUREN A. MATISE, PH.D. New York, NY Vice President Business Development Manager, Bridge Growth Partners Metabolic Pathways & CV JEN O’NEILL New York, NY GlaxoSmithKline Senior Brand Manager, King of Prussia, PA Brand Lead - Plan B One-Step ADAM M. KOPPEL. M.D., PH.D. Teva Women’s Health Managing Director JEAN MELLETT Frazer, PA Bain Capital (Life Sciences Fund) System Director, Planning and Strategy Boston, MA Eastern Maine Healthcare Systems JUSTIN PALLARI Brewer, ME Independent Consultant DEEPA KUMARAIAH, M.D. New Delhi, India Assistant Chief Medical Officer MICHAEL C. MENG (Asst. Prof. Med.-Div. Cardiology); Principal JAMES PARADIS Advisor to NYP Ventures Apax Partners President New York Presbyterian Hospital New York, NY Paoli Hospital New York, NY Main Line Health AUDREY MEYERS Paoli, PA DAVID LAMACCHIA President/Chief Executive Officer Vice President, Corporate Development The Valley Hospital SHAUNAK PARIKH Prospira PainCare /Valley Health System Principal Roswell, GA Ridgewood, NJ EW Healthcare Partners New York, NY RICHARD LEE, M.D. GEOFF MEYERSON Assistant Professor Managing Director and Co-founder MAMTA PATEL Weill Cornell Medical College Locust Walk Partners Project Leader New York, NY Cambridge, MA Flatiron Health New York, NY

34 MITESH S. PATEL, M.D. ALCIRA RODRIGUEZ SONAL SHAH Assistant Professor Senior Consultant Senior Manager Perelman School of Medicine/ Deloitte Consulting Deloitte Center for Health Solutions Wharton School New York, NY New York, NY Philadelphia, PA FRED RONNAU JONATHAN SHANNON MONA PATEL Chief Operating Officer Manager Vice President of Clinical Training Pivotal Innovation Deloitte Consulting, LLP and Fellowship Education Highlands Ranch, CO Atlanta, GA Boston Scientific Valencia, CA BENJAMIN M.W. ROOKS DAVID A. SHEEHY Managing Director Chief Operating Officer CARY G. PFEFFER, M.D. ST Advisors, Inc. Sage Growth Partners Partner San Francisco, CA Baltimore, MD Third Rock Ventures Boston, MA MICHAEL ROVINSKY DANIEL A. SIMON Director, Southeast Region Vice President JOHN P. PICASSO Veralon BioPharma Business Development Analyst Atlanta, GA Guardant Health Pzena Investment Management Redwood City, CA New York, NY AARON ROYSTON Principal ANNE E. SISSEL MATTHEW PICKENS venBioPartners Vice President & Head, Ventures Regional Director San Francisco, CA Baxter Healthcare Press Ganey Asociates Chicago, IL Winter Park, Fl ANIL SAGGI Category Marketing Manager PAULINA SOCKOLOW DAVID PINKERT Nordics, Consumer Health Associate Professor Co-founder and President GlaxoSmithKline Consumer Health Drexel University Friday Health Plans, Inc. Sweden Philadelphia, PA Denver, CO JOE SCATTERGOOD GAYLE SQUIRES, M.D. SALLY POBLETE Associate Director, Marketing Independent Consulting Founder and Chief Executive Officer Loxo Oncology Gayle L. Squires M.D., LLC Wellthie Stamford, CT New York, NY New York, NY STEVE SCHRODEL ROSS D. STERN DONNA BRADY RAZIANO, M.D. Vice President, Operations Vice President Chief Medical Officer Iora Health Summit Partners Mercy Health System, Mercy Home Boston, MA Boston, MA & Community Health Services Philadelphia, PA JOHN SCHWARZ SUSAN STIMSON Vice President, Administration General Manager, SINUVA ERIC REDLINE Lankenau Medical Center, Intersect ENT Vice President, Customer Engagement Main Line Health Menlo Park, CA Aktana Wynnewood, PA San Francisco, CA STEVE SWEENY KENNETH C. SEGARNICK Director, BHOHATHAI REMALEY Chief Corporate Officer Corporate Development Vice President Brandywine Senior Living Medtronic DaVita Healthcare Partners Mt. Laurel, NJ San Francisco, CA Singapore ROBERT R. SELTZER CRAIG P. TANIO, M.D. JAMES RHODES Managing Partner Chief Executive Officer & Founder Senior Director, Lucena Capital Rezilir Health Strategy and Business Development New York, NY Boca Raton, FL Children’s Health Dallas, TX ANKIT SHAH MARLON THOMPSON Director of Marketing Vice President, JAMES F. RICHTER Intersect ENT Image Analysis & Clinical Solutions Vice President, Business Development Menlo Park, CA Leica Biosystems (a Danaher company) ReMed Newcastle, UK Paoli, PA RAVI N. SHAH, M.D. Medical Director DAN THORNTON EDMONDO J. ROBINSON, M.D. Columbia Psychiatry Faculty Vice President, Market Access Chief Transformation Officer Practice Organization Flexion Therapeutics Christiana Care Health Services New York, NY Wellesley, MA Wilmington, DE

35 Health Care Program Mentors

ERIC TREPANIER Group Vice President, Marketing Sciences WebMD New York, NY

MAYA TSUKERNIK Principal The Boston Consulting Group New York, NY

JOHN URQUHART Principal HealthCare Royalty Partners Boston, MA

LISA VARSHNEY Executive Vice President, Relationship Lead / Head of Strategy Heartbeat New York, NY

JEFFREY VOIGT Principal Medical Device Consultants of Ridgewood LLC Ridgewood, NJ

OFER WAKS Oncology Marketing Brand Lead Shire Cambridge, MA

LYNN WANG Director of Product Management Weight Watchers San Francisco, CA

YIZHE WANG Head of Respiratory Sales, China Pharmaceuticals GlaxoSmithKline Princeton, NJ

CHRIS WILKERSON President EquipSystems, LLC New York, NY

ANDREW W.WONG Senior Vice President, Corporate Business Development Capella Biosciences, Inc. Palo Alto, CA

CHIA H. WU, M.D. Resident Physician University of Pennsylvania Health System Philadelphia, PA

DANIEL YIP Head of U.S. Marketing Intercept Pharmaceuticals New York, NY

ELLEN S. YOON Global Cognitive & Analytics Insurance Leader, GBS Partner IBM Corp. New York, NY

THOMAS ZIPP Marketing Director, Cough & Cold Portfolio Vernalis Therapeutics, Inc. Exton, PA

36 Administration

GEOFFREY M. GARRETT, PH.D. Dean, The Wharton School

HOWARD KAUFOLD, PH.D. Vice Dean and Director, The Wharton Graduate Division

SCOTT E. HARRINGTON, PH.D. Chair, Health Care Management Department, The Wharton School; Director, MBA Program in Health Care Management

JUNE M. KINNEY, M.A. Associate Director, MBA Program in Health Care Management

CHRISTINE ALESZCZYK Administrative Coordinator, MBA Program in Health Care Management

JANICE SINGLETON Administrative Coordinator, MBA Program in Health Care Management

37 Faculty

The Program Faculty are drawn from EZEKIEL J. EMANUEL, M.D., PH.D. JUNE M. KINNEY, M.A. the Wharton School, the School of Diane v.S. Levy and Robert M. Associate Director, Graduate Program Levy University Professor and in Health Care Management; Medicine, the School of Nursing, and Vice Provost for Global Initiatives; Lecturer, Health Care Management, the School of Arts and Sciences at the Professor, Health Care Management, The Wharton School University of Pennsylvania and leading The Wharton School GARY J. KURTZMAN, M.D. health institutions in Philadelphia. BRADLEY M. FLUEGEL Vice President, Life Sciences, Additional support is provided by the Senior VP & Chief Strategy Safeguard Scientifics; Lecturer, Officer, Walgreens; Health Care Management, Fellows and Associates of the Leonard Lecturer, Health Care Management, The Wharton School Davis Institute of Health Economics. The Wharton School JEFFREY P. LIBSON, J.D. THOMAS N. GILMORE, M.ARCH. Partner, Cooley; Vice President, Lecturer, Health Care Management, The Center for Applied Research Inc.; The Wharton School ABBY E. ALPERT, PH.D. Senior Fellow, Health Care Management, HARI MAHADEVAN, PH.D. Assistant Professor, The Wharton School Health Care Management, Independent Consultant; The Wharton School JOHN P. GLASER, PH.D. Lecturer and Senior Fellow, Senior Vice President, Client Health Care Management, EUGENIO ANESSI, PH.D. Administration, Cerner Corporation; The Wharton School Professor, Public Management, Lecturer, Health Care Management STEVEN A. NICHTBERGER, M.D. Bocconi University Graduate School The Wharton School of Management, Milan, Italy; Adjunct Professor and Senior Fellow, Lecturer and Senior Fellow, HENRY A. GLICK, PH.D. Health Care Management, Health Care Management, Professor of Medicine, The Wharton School The Wharton School Perelman School of Medicine at MITESH S. PATEL, M.D. the University of Pennsylvania; Assistant Professor of Medicine, Perelman DAVID A. ASCH, M.D., M.B.A. Professor, Health Care Management, School of Medicine at the University Executive Director, The Wharton School Penn Medicine Center for Health of Pennsylvania School of Medicine; Care Innovation; MATTHEW R. GRENNAN, PH.D. Assistant Professor of Health Care Professor of Medicine, Assistant Professor, Management, The Wharton School Perelman School of Medicine Health Care Management, MARK V. PAULY, PH.D. at the University of Pennsylvania; The Wharton School John M. and Thomas L. Bendheim Professor, Health Care Management, Professor; Professor, Health Care The Wharton School ATUL GUPTA, PH.D. Management, Business Economics and Assistant Professor, Public Policy, The Wharton School; THOMAS E. BAKER, J.D. Health Care Management, Professor, Economics, College of Arts William Maul Measey Professor of The Wharton School Law and Health Sciences, University and Sciences of Pennsylvania Law School; SCOTT E. HARRINGTON, PH.D. WILLIAM P. PIERSKALLA, PH.D. Professor of Health Care Management, Chair, Health Care Management Professor Emeritus The Wharton School Department, and Director, Health Care Management Program, DANIEL POLSKY, PH.D. LAWTON R. BURNS, PH.D., M.B.A. The Wharton School Robert D. Eilers Professor of Health Care James Joo-Jin Kim Professor of Health Alan B. Miller Professor of Health Care Management and Economics, Care Management, The Wharton School; Management and Business Economics The Wharton School; Faculty Co-Director, and Public Policy, The Wharton School Professor of Medicine, Roy and Diana Vagelos Program Perelman School of Medicine In Life Sciences & Management ERIC M. HEIL at the University of Pennsylvania; SVP, Chief Commercial Officer Executive Director, Leonard Davis PATRICIA M. DANZON, PH.D. Software Solutions, NaviHealth, Inc.; Institute of Health Economics Celia Z. Moh Professor Emeritus Lecturer, Health Care Management, of Health Care Management, The Wharton School The Wharton School JOHN C. HERSHEY, PH.D. GUY DAVID, PH.D. Anheuser-Busch Professor Emeritus Gilbert and Shelley Harrison of Management Science; and Associate Professor, Health Care Management, Health Care Management, The Wharton School The Wharton School JOHN KIMBERLY, PH.D. BENJAMIN DORANZ, PH.D., M.B.A. Henry Bower Professor of Entrepreneurial President and CEO, Integral Molecular, Studies; Professor of Management, Inc.; Senior Fellow, Health Care Health Care Management, and Sociology, Management, The Wharton School The Wharton School

38 DOUGLAS A. PRESENT, M.B.A. RACHEL M. WERNER, M.D., PH.D Investor and Advisor; Associate Professor of Medicine, Lecturer, Health Care Management, Perelman School of Medicine at the The Wharton School University of Pennsylvania School of Medicine; Associate Professor and Senior ARNOLD J. ROSOFF, J.D. Fellow, Operations and Information Professor Emeritus, Management, Health Care Management, Legal Studies and Business Ethics; The Wharton School Lecturer, Health Care Management, The Wharton School JOHN J. WHITMAN, M.B.A. Executive Director, The TRECS Institute; STEPHEN M. SAMMUT Lecturer, Health Care Management, Lecturer and Senior Fellow, The Wharton School Health Care Management, Lecturer, Entrepreneurial Programs, SANKEY V. WILLIAMS, M.D. The Wharton School Professor of General Internal Medicine; Professor, CYNTHIA SCALZI, M.N., PH.D. Health Care Management, Professor Emeritus of Nursing The Wharton School and Health Care Management, The Wharton School

J. SANFORD SCHWARTZ, M.D. Leon Hess Professor in Internal Medicine, Perelman School of Medicine at the University of Pennsylvania; Professor, Health Care Management, The Wharton School

JEFFREY H. SILBER, M.D., PH.D. Director, Center for Outcomes Research, The Children’s Hospital of Philadelphia; Professor of Pediatrics and Anesthesiology & Critical Care, The University of Pennsylvania Perelman School of Medicine at values diversity and seeks talented the University of Pennsylvania; students, faculty and staff from diverse Professor, Health Care Management, backgrounds. The University of The Wharton School Pennsylvania does not discriminate on the basis of race, sex, sexual JEFFREY A. SOLOMON, M.D., M.B.A. orientation, gender identity, religion, Founding Partner, Infiniti Medical LLC; color, national or ethnic origin, age, Lecturer, Health Care Management, JUNE KINNEY disability, or status as a Vietnam Era The Wharton School Associate Director, MBA Program Veteran or disabled veteran in the in Health Care Management administration of educational policies, ASHLEY SWANSON, PH.D. The Wharton School programs or activities; admissions Assistant Professor, policies; scholarship and loan awards; Health Care Management, athletic, or other University adminis- The Wharton School tered programs or employment. KEVIN G.M. VOLPP, M.D., PH.D. Questions or complaints regarding Director, Center for Health Incentives this policy should be directed to: and Behavioral Economics, Executive Director, Leonard Davis Institute; Office of Affirmative Action Professor of Medicine, and Equal Opportunity Programs Perelman School of Medicine Sansom Place East at the University of Pennsylvania; 3600 Chestnut Street, Suite 228 Professor, Health Care Management, Philadelphia, PA 19104-6106 The Wharton School 215.898.6993 (Voice) 215.898.7803 (TDD)

©2004, The Trustees of the University of Pennsylvania. All rights reserved.

SCOTT E. HARRINGTON, PH.D. Director, MBA Program in Health Care Management, Photography of Students: adamgierkephotography.com The Wharton School Book Design: www.HollisterCreative.com

39 Wharton The Wharton School University of Pennsylvania

MBA Program in Health Care Management 3641 Locust Walk Philadelphia, PA 19104-6218

215.898.6861 fax 215.573.2157